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Background: During the last four decades obesity has grown to be a global epidemic. 
Simultaneously with the growing obesity prevalence, mean population levels of 
cardiometabolic risk factors like total cholesterol and blood pressure have decreased in high-
income countries. Thus, there has been a paradoxical trend of increase in obesity and decrease 
in other cardiometabolic risk factors. Body mass index (BMI) and waist circumference are the 
most frequently used measures to define general and abdominal obesity. However, these 
anthropometric measures cannot distinguish between different compositions of the body and 
are prone to measurement error. While anthropometry are proxy measures, more precise 
measures of excess fat accumulation can be studied with dual-energy X-ray absorptiometry 
(DXA) scans, including total body fat and visceral adipose tissue (VAT). VAT is recognized 
as the most metabolically active and harmful fat tissue with the highest association with 
cardiometabolic risk. As such, it is possible that BMI and waist circumference fail to 
represent the actual obesity status and the health risks associated with obesity in the 
population. The paradox between the decrease in cardiometabolic risk and the increase in 
obesity prevalence may reflect that populations attain more fat mass or muscle mass, while 
not increasing the more harmful VAT mass. 
Aim: The aim of this thesis was to use a population-based study sample to a) establish 
reference values and suggest threshold values for DXA-derived VAT in a general population 
of adult women and men, b) to compare VAT with anthropometric measures and their 
association with cardiometabolic risk factors and the metabolic syndrome (MetS), and c) to 
study time trends in body composition including total body fat-, lean- and VAT mass during 
the last two decades. 
Methods: All analyses were based on data from participants attending the Norwegian 
population-based Tromsø Study. In paper Ⅰ we included 3675 women and men aged 40-84 
years from the seventh survey of the Tromsø Study (2015-2016) with valid measurements of 
VAT and cardiometabolic risk factor measures. We used Receiver Operating Characteristics 
(ROC) analyses and c-statistics to investigate different units of VAT (grams, index [VAT 
grams/ body height2], and percent (%) [VAT grams/ total fat in abdominal area * 100]) in 
association with MetS and single MetS components (hypertension, diabetes, elevated 
triglycerides, and low high-density lipoprotein [HDL] cholesterol). Youden’s index was used 
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paper Ⅰ, in addition to anthropometric measures (BMI, waist circumference, waist-to-hip ratio 
and waist-to-height ratio). We used ROC analyses and c-statistics to compare the association 
between VAT and MetS with the corresponding relationship between anthropometrics and 
MetS. In Paper III we included 1662, 901 and 3670 participants from the fifth (2001), sixth 
(2007-2008) and seventh (2015-2016) survey of the Tromsø Study, respectively, to study 
secular and longitudinal population trends in fat mass, VAT mass and lean mass using 
descriptive statistics and generalized estimation equation models.  
Results: We presented reference values for women and men in 10-year age-groups, and for 
three measurement units of VAT (grams, index and %). The thresholds presented based on 
cardiometabolic risk were ≥1134 grams, index ≥0.44, and ≥40%, in women. In men, the 
thresholds were ≥1859 grams, index ≥0.55 and ≥61%. We found that VAT was strongly 
correlated with the anthropometric measures, but VAT was also statistically significantly 
stronger than the anthropometric measures in the prediction of MetS and single MetS 
components. However, the observed difference in Area Under the Curves (AUCs) were minor 
to non-existing. Further, we found that both VAT and fat mass increased in the population 
from 2001 to 2015-2016, with a larger increase in the most recent period (between 2007-2008 
and 2015-2016), as well as for the youngest birth-cohort (40-49 years in 2001, particularly in 
women). Total lean mass remained stable over the three surveys. 
Conclusion: The presented reference- and threshold values are valuable for future studies, 
clinical populations, and patient groups using DXA-derived VAT measured with the same 
system, protocols and in similar populations as ours. Secondly, although VAT was 
statistically stronger associated in predicting MetS than anthropometric measures, the clinical 
differences were minor, and the more commonly used anthropometric measures can be 
regarded as satisfactory substitutes for VAT. Finally, the observed trends of DXA-derived 
VAT and total body fat from 2001 to 2015-2016 are in accordance with the increasing trends 
in overweight and obesity presented by previous research using anthropometric measures. The 
increasing trends in VAT and total body fat were highest in the younger birth-cohorts. We 
conclude that the increase in obesity and the paradoxical concurrent decrease in other 
cardiometabolic risk factors cannot be explained by an increase in muscle mass, but rather a 





Introduksjon: Fedme har vokst til å bli en global epidemi. Det er et paradoks at mens 
forekomsten av overvekt og fedme øker i verdens befolkning de siste ti-årene, har det 
samtidig vært en nedgang i andre kardiometabolske risikofaktorer som totalkolesterol og 
blodtrykk. Antropometriske mål som kroppsmasseindeks (KMI) og midjemål er de vanligste 
målene for å kartlegge vekt og følge trender i overvekt og fedme over tid. Verken KMI eller 
midjemål skiller mellom ulike kroppssammensetninger, og begge er disponert for målefeil. 
Dual-energy x-ray (DXA) skanning gir en mer nøyaktig måling av kroppssammensetning, og 
dermed et mer nøyaktig mål av både totalt fettvev og visceralt fett (VAT). VAT er det mest 
metabolsk aktive fettvevet og er sterkt knyttet til kardiometabolsk risiko. Det er derfor mulig 
at KMI og andre vanlige antropometriske mål ikke representerer reell overvekt og fedme, 
samt risiko for fedmerelaterte helseutfordringer i befolkningen. Paradokset mellom nedgang i 
kardiometabolske risikofaktorer og økende forekomst av fedme kan muligens forklares av at 
populasjoner blir fetere eller mer muskuløse, men ikke nødvendigvis øker i det mer 
helsefarlige viscerale fettet.  
Mål: Målet med denne avhandlingen var å bruke en populasjonsbasert studie for å a) etablere 
referanseverdier og terskelverdier for VAT målt med DXA i en generell populasjon bestående 
av voksne kvinner og menn, b) sammenligne VAT med de hyppigst brukte antropometriske 
målemetodene og deres assosiasjon til metabolsk syndrom (MetS), og c) undersøke endringer 
i kroppssammensetning i befolkningen over tid, inkludert totalt kroppsfett, VAT og fettfri 
masse gjennom de to siste ti-årene. 
Metode: Alle analyser baserte seg på data fra deltakere i den befolkningsbaserte 
Tromsøundersøkelsen. I artikkel Ⅰ inkluderte vi 3675 kvinner og menn (40-84 år) fra den 
syvende Tromsøundersøkelsen (2015-2016) som hadde mål på VAT og kardiometabolske 
risikofaktorer. Vi brukte ROC-analyser og c-statistikk for å undersøke ulike enheter av VAT 
(gram, indeks [VAT gram/ høyde2], og prosent [VAT gram/ totalt abdominal fett * 100]) og 
assosiasjoner til MetS og enkeltstående MetS-komponenter (hypertensjon, diabetes, 
forhøyede triglyseridnivåer og lavt HDL-kolesterol). Youden’s indeks ble brukt for å lage 
terskelverdier for VAT. I artikkel Ⅱ ble samme utvalg som i artikkel Ⅰ inkludert. I tillegg til 
variablene beskrevet for artikkel Ⅰ inkluderte vi antropometriske målinger (KMI, 
midjeomkrets, midje-hofte-ratio og midje-høyde-ratio). Vi brukte ROC-analyser og c-
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3670 deltakere fra Tromsø 5 (2001), Tromsø 6 (2007-2008) og Tromsø 7 (2015-2016) for å 
undersøke sekulære og longitudinelle tidstrender i kroppssammensetning ved bruk av 
beskrivende statistikk og «generalized estimation equation». 
Resultater: Vi presenterte referanseverdier for både kvinner og menn i 10-års aldersgrupper, 
og for tre måleenheter av VAT (gram, indeks og %). Terskelverdiene presentert for VAT 
gram, indeks og % var henholdsvis ≥1134, ≥0,44 og ≥40 hos kvinner og ≥1859, ≥0,55 og ≥61 
hos menn. Vi fant at VAT var sterkt korrelert med de antropometriske målene, men i 
prediksjon av MetS og enkeltstående komponenter av MetS var VAT statistisk sterkere enn 
de antropometriske målene. De observerte forskjellene mellom AUC-estimatene var dog små. 
Videre fant vi at både VAT og totalt kroppsfett økte i befolkningen fra 2001 til 2015-2016, 
med en større økning fra i siste periode (fra 2007-2008 til 2015-2016) samt i den yngste 
fødselskohorten (40-49 år, aldersforskjellen var kun signifikant hos kvinner). Total 
muskelmasse var stabil i de tre undersøkelsene.  
Konklusjon: Referanse- og terskelverdiene av VAT er verdifull for fremtidige studier, 
kliniske populasjoner eller andre pasientgrupper som bruker VAT målt med samme DXA-
utstyr, og på lignende populasjon som i denne studien. Vi fant ut at selv om VAT var 
statistisk sterkere assosiert med MetS, var de kliniske forskjellene mellom VAT og 
antropometriske mål minimale og de hyppig brukte antropometriske målene er 
tilfredsstillende erstatninger for VAT i populasjonsstudier. Til slutt viste vi at tidstrendene i 
VAT og kroppsfett i befolkningen fra 2001 til 2015-2016 sammenfaller med tidligere 
observerte trender i KMI og midjemål, også i henhold til aldersavhengige trender. Basert på 
våre resultater konkluderer vi med at paradokset mellom økende forekomst av overvekt og 
fedme, samtidig med nedgang i andre kardiometabolske risikofaktorer ikke kan forklares ved 
en økning i muskelmasse, men at det er en reell økning i kroppsfett. Fedme består som en av 
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1 Introduction  
The main topic of this thesis is body composition, abdominal obesity, and cardiometabolic 
health. Overweight and obesity are long-standing challenges to health. The continuous 
increase in the prevalence of overweight and obesity in both developed and developing 
countries, together with the close links to non-communicable diseases like cardiovascular 
disease, diabetes, cancer, and mental health underline the need for effective preventive 
measures (1-4). Most studies of overweight and obesity have used body mass index (BMI) or 
waist circumference to address associations with health outcomes and to assess trends. These 
commonly used anthropometric measures does not distinguish between fat mass and fat free 
mass, thus does not directly address the definition of overweight and obesity, aiming on 
identifying body fatness. Therefore, it is unclear whether increased BMI actually represents 
an unhealthy increase in total body fat, or if it reflects an increase in muscle mass in the 
population. Concurrent with the continuing increase in overweight and obesity in the last 
decades, risk factors associated with non-communicable diseases, like blood pressure (5), 
total cholesterol (6, 7), and overall cardiovascular risk (8-10) have decreased in developed 
countries. This implicates a paradoxical trend towards better overall population health despite 
a concurrent increase in obesity prevalence. This contradiction raises the question as to 
whether the anthropometric measures currently used to reflect overweight and obesity are 
accurate enough, or if more accurate measures are needed. Further, we questioned whether the 
paradoxical observation might be caused by an increase in fat mass, but not necessarily an 
increase in visceral fat mass. These theorizations form the background for this thesis, where 
we have investigated visceral adipose tissue (VAT) in association with the commonly used 
anthropometric measures, associations with cardiometabolic risk, and body composition 








  Overweight and obesity 
1.1.1 Definition 
Overweight and obesity are defined as “abnormal or excessive fat accumulation that may 
impair health” (11), and is most commonly classified by BMI. BMI is a clinically available 
and easy method to use and is calculated as weight (kg) divided by height (m) squared. BMI 
is further classified into different categories (Table 1). 
Table 1: Categories of body mass index as defined by the World Health Organization 
<18.5 Underweight 
18.5-24.9 Normal weight 
25.0-29.9 Overweight/pre-obesity 
30.0-34.9 Obesity class Ⅰ 
35.0-39.9 Obesity class Ⅱ 
≥40 Obesity class Ⅲ 
(12, 13) 
Another commonly used measurement tool to classify obesity, and more specifically 
abdominal obesity, is waist circumference. Waist circumference is measured by a stretch-
resistant measuring tape around the abdominal area. The exact placement of the tape differs 
according to different protocols (14). Waist circumference is classified into categories based 
on level of risk for disease (Table 2). 
Table 2: Categories of waist circumference as defined by the World Health Organization 
 Disease risk 
 Increased risk  Substantially increased risk 
Women > 80 cm > 88 cm 





BMI and waist circumference are currently the most frequently used measures to quantify 
overweight and obesity, but regarding their clinical feasibility, they have both been criticized 
for their limited potential to address the actual definition of overweight and obesity and for 
being prone to measurement error (15-17). BMI represents overall body weight in relation to 
height but does not consider the actual proportions of body fat or muscle mass (15, 16). Thus, 
both excess fat mass and large muscle mass will give higher BMI, although increased muscle 
mass is not considered as overweight/obesity, nor associated with increased risk for disease. 
This limitation of BMI might lead to categorization of individuals with a large muscle mass 
and average height as overweight or obese. Likewise, individuals with low muscle mass and 
excess adiposity might be considered as normal weight. Waist circumference may also be 
affected by overall body size in that a large muscular person might have a larger waist area 
compared to a less muscular person, although they do not differ in risk for disease. Waist 
circumference is also highly prone to measurement error (17). The accuracy depends on the 
individual taking the measure, type of measurement tape and adherence to or use of a standard 
operation procedure. Other commonly used anthropometric measures are waist-to-hip ratio 
(WHR) (waist [cm]/hip [cm]) and waist-to-height ratio (WHtR) (waist [cm]/height [m]2) (14, 
18, 19). These measures are suggested as better at reflecting the core problem of overweight 
and obesity – namely body composition and distribution of fat, but no anthropometric 
measure is uniformly accepted as superior in disease prediction than other anthropometric 
measures. Thus, new measures to quantify body composition and association with morbidity 
are continuously created. Examples of such new measures are A Body Shape Index (ABSI) 
(waist/[BMI2/3*height1/2]) (20, 21) and WHT.5R (waist/height0.5) (22), which are suggested as 
more accurate in prediction of obesity related disease than the more traditionally used 
measures.  
1.1.2 Prevalence of overweight and obesity  
The global obesity prevalence has tripled in the last four decades, and each year more than 2.8 
million deaths can be attributed to overweight and obesity (23, 24). Among adults older than 
18 years, almost 2 billion people were overweight in 2016. Of these, more than 250 million 
people suffered from obesity. The NCD Risk Factor collaboration presented that BMI 
continously increased in adults from 1975 to 2016 (25). 
The prevalence of overweight and obesity in Norway has increased continuously the last 
decades and in 2017 the majority of the population had overweight or obesity according to the 
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classification of BMI (12). In both Norway and other countries, a steady increase in 
overweight and obesity measured as both BMI and waist circumference has been observed, 
with a larger increase in the younger part of the population (26-33). The Health status report 
in Norway in 2018 presented that, although several positive trends in major risk factors are 
observed in the Norwegian population, the goal to halt the increase in proportion of people 
with obesity and diabetes is not being achieved (34).  
  Health consequences of overweight and obesity 
Several health consequences can be attributed to overweight and obesity. From childhood to 
adulthood there are complex, multidisciplinary, and interchangeable factors leading to 
overweight and obesity. These are further associated with numerous health issues with 
individual physical- and psychological consequences, and an economic burden for the society 
and health care services. Obesity can either serve as a direct cause for disease, or as an 
indirect cause, meaning that obesity leads to an increase in other risk factors for disease, such 
as increase in blood pressure, which in turn increase the risk of cardiovascular disease. 
Overall, excessive weight and high BMI alone (with absence of metabolic disturbances) 
might affect health through conditions such as musculoskeletal disorders and mental health 
problems. Further, obesity and especially abdominal obesity, is strongly associated with 
cardiometabolic disease and metabolic disturbances. Fat distribution and the effect of 
different phenotypes of obesity on health are highly important, and in particular high VAT 
mass is strongly associated with cardiometabolic disease (35). Both visceral obesity and 
severe general obesity should be identified and targeted to reduce the risk for obesity-related 
diseases.  
1.2.1 Risk factors for disease – overweight as indirect cause 
Overweight and obesity are linked to several cardiometabolic risk factors. Through 
mechanisms such as excess release of fatty acids, ectopic lipid accumulation (storing of fat in 
liver and organs), low-grade systemic inflammations, increased level of pro-inflammatory 
adipocytokines, and endothelial dysfunction, abdominal obesity can cause insulin resistance, 
type 2 diabetes, dyslipidemia, have an effect on the hemodynamic system including cardiac 
structure and function, and lead to neurohormonal disturbances and metabolic dysregulation 
(35). In 2019, high systolic blood pressure, smoking, and high fasting plasma glucose were 
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the leading risk factors for death and disability globally, and high systolic blood pressure 
accounted for 10.8 million deaths worldwide (36).  
1.2.2 Diseases and mortality 
In 2019, BMI was ranked as one of the leading risk factors for death and disability globally, 
and further one of the risk factors that had increased most since 1990 (36). In 2015, more than 
4 million deaths worldwide could be attributed to high BMI, and more than two thirds of 
these deaths were due to cardiovascular disease (1). After cardiovascular disease, the leading 
causes of deaths attributable to BMI was diabetes, followed by chronic kidney disease and 
certain cancers (1). A substantial part of the association between obesity and disease is 
mediated through the cardiometabolic risk factors presented above.  
Cardiometabolic disease 
The term cardiometabolic disease includes both cardiovascular and metabolic disturbances. 
Both single risk factors, like hypertension and dyslipidemia, as well as established disease 
such as diabetes and atherosclerotic cardiovascular disease (coronary heart disease and 
ischemic stroke) are included in this definition. Metabolic syndrome (MetS) is a commonly 
used definition for metabolic abnormalities. Several different definitions of MetS exist (37), 
but one frequently used definition is the National Cholesterol Education Program Adult 
Treatment Panel (NCEP ATP) Ⅲ, which defines MetS as presence of three or more of the risk 
factors presented in Figure 1. 
Obesity is related to both an increase in cardiovascular risk factors, and to increased risk of 
adverse cardiovascular outcomes like myocardial infarction, heart failure, atrial fibrillation, 
and ischemic stroke (35). Further, obesity is strongly associated to the development of 
diabetes type 2, and about 80% of people with diabetes have overweight or obesity (3). The 
mechanisms linking obesity to increased cardiometabolic risk are a complex interplay shortly 





Figure 1: Metabolic syndrome and the single components of the metabolic syndrome criteria 
defined by the NCEP ATP Ⅲ criteria (37) 
 
Other diseases and conditions 
After smoking, overweight and obesity are the most common preventable risk factors for 
cancer (38), and more than 10% of cancers are attributable to obesity (39). Obesity is 
associated with cancers in for example the esophagus, colon and rectum, liver, gallbladder 
and biliary tract, pancreas, breast, uterus, ovary and thyroid, as well as leukemia (1). The 
mechanisms linking obesity to cancer is thoroughly explained elsewhere (39). With the 
continuous increase in obesity together with the decline in smoking it is reasonable to assume 
that overweight and obesity will soon be the leading preventable risk factors for cancer.  
Further, excess body weight may lead to functional disabilities, pain and musculoskeletal 
disorders such as osteoarthritis, low back pain, and fibromyalgia (40). In 2015, about 5% of 
disability adjusted life years related to high BMI were due to musculoskeletal disorders (1). In 
Norway, musculoskeletal conditions are the main reason for sick-leave (from work), non-fatal 
loss of health, and for the total disease burden in the adult working population (34). However, 
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overweight has also been shown to serve as a protective factor for osteoporosis in the elderly 
(41). 
Psychological, mental, and cognitive health can be influenced by overweight and obesity. 
Although the causality between overweight/obesity and these conditions are difficult to 
establish, there is inevitably challenges linked to self-confidence and social stigma. Further, 
overweight and obesity has been linked to low self-esteem, mood disorders, eating disorders, 
impaired body image, and quality of life (2). Psychological health challenges and 
overweight/obesity, might be associated in a vicious circle further leading to humiliation, 
rejection, and social bias (2).  
All-cause mortality  
The association between overweight and all-cause mortality has not always been clear. In 
2013 a large review (42) presented that people with overweight had a lower mortality risk 
compared to people with normal weight. On the other hand, people with obesity (above class 
Ⅰ) had a higher mortality. Class Ⅰ of obesity (BMI 30-35 kg/m2) was not significantly 
associated with higher mortality, suggesting that the higher risk from overall obesity is 
actually attributable to BMI levels of 35 kg/m2 or higher (obesity class Ⅱ or Ⅲ) (42). This 
corresponds to findings from the Global Burden of Disease project where, of the 4 million 
deaths globally attributable to high BMI, more than 60% was due to BMI levels of 30 kg/m2 
or more (1). More recently it has been questioned whether reverse causation of BMI might 
affect the observations between obesity and mortality, and whether this could explain why 
overweight seems protective compared to normal weight. Current weight status might be 
influenced by disease incidence, although incident disease or mortality could also be 
influenced by weight status earlier in life. Further, those who are normal weight at the time of 
examination could have been overweight or obese before. In 2018 Xu et al. (43) investigated 
the maximum BMI in cohort studies prior to follow-up and found that the mortality increased 
linearly with increasing maximum BMI. This implies that increasing levels of overweight 
increase the risk for disease, and that the results showing lower risk in overweight compared 
to normal weight might be caused by other factors. Risk of mortality attributed to body 
weight is not only related to overweight and obesity, but also to underweight. This finding is 
more frequent in the older adult population where weight loss due to loss of muscle mass and 
function, known as sarcopenia (44), is more common. In a Norwegian study the association 
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between both BMI and waist circumference with mortality were U-shaped in adults 65 years 
and older (45). However, a large review and meta-analysis from 2016 (46) showed that the U-
shaped association between BMI and mortality was, to some extent, driven by confounding 
factors such as smoking, disease or short follow-up. Nonetheless, overweight and obesity 
during the life-course are associated with higher all-cause mortality, cardiovascular mortality, 
cancer mortality, death from diabetes or accidental death even after adjusting for smoking and 
disease status (3).  
Economic burden and association with socio-economic status 
In addition to the individual consequences of having obesity, the economic burden for the 
health care service including the increased need of care, hospitalization and medication use 
brings negative consequences for the whole society. Given the consistent increase in 
overweight/obesity, and the strong association with most non-communicable diseases, 
increased health care costs and burden are inevitable. Prevalence of obesity is associated with 
more frequent use of health care services, higher prevalence of surgery and more frequent 
need of prescriptive medications compared to normal weight status (4). In addition, people 
with obesity are prone to have lower wages, more sick leave, and more unemployment (4). In 
Norway the total societal costs attributed to obesity were estimated to 70 billion Norwegian 
kroner per year. Further, the costs of obesity-related diseases were estimated to 40 billion 
kroner per year (47). Loss of income and costs for sick-leave and disability attributed to 
obesity were 17 billion kroner/year, and health care expenses attributable to obesity were 12 
billion kroner/year. Combined, these costs make obesity the most costly public health 
challenge in Norway (47). 
Further, the association between socioeconomic status (SES) and obesity is negative in high-
income countries, meaning that people with lower SES more often have a larger body size 
(48). This is potentially explained by a more unfavorable energy balance among people with 
lower SES originating from the higher costs of low energy dense and healthy foods, as 
compared to lower costs of high energy dense food (48). Thus, healthy foods become less 
accessible for those with lower SES and the risk for obesity increases. Also, people with 
obesity are observed to have lower levels of physical activity, suggested to partly be 
explained by lack of recreational facilities mediated through SES (48). The negative 
association between obesity and SES is also shown in children, where children and 
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adolescents with obesity has lower performance at school and are more likely to miss school 
days (4). This might further lead to lower SES in adulthood causing a vicious circle between 
SES and obesity. 
  Body composition 
The body consists of several tissue types, divided into different components based on 
measurement method. DXA uses a three-compartment model, dividing the body into three 
main components; fat mass, lean mass and bone mineral content, from where the two first 
constitute the main part of the composition of the total body.  
When studying sarcopenia and muscle loss in the elderly, muscle mass, and more specifically 
appendicular muscle mass (muscle mass in arms and legs) is often assessed (49). When 
studying overweight and obesity, fat mass is most relevant. Individuals with similar BMI may 
have significantly different amount and distribution of body fat. Further, different areas of fat 
distribution have different health impact, therefore examining the area of fat accumulation is 
essential. Also, establishing the distribution of subcutaneous fat relative to VAT is important 
and has been advocated in previous research (50, 51). VAT is fat located intraabdominally, 
behind the abdominal muscles and around organs, and is more harmful than subcutaneous fat, 
partly because of its close location to organs such as the liver (50) (Figure 2). VAT serves as 
protective padding to the organs and is involved in fat metabolism. With increasing size of 
VAT the metabolic activity and effect on other organs is enhanced (52).  
The effects of VAT are comprehensive, and the physiological effects and implications are 
only slightly addressed in the current thesis to highlight the health challenges related to 





Fat tissue is mainly constituted by fat cells called adipocytes. When the intake of energy 
exceeds the energy expenditure, the adipocytes have two ways to increase their storage - 
expand in numbers (limited possibilities) or expand in size. Thus, VAT as other fat tissues 
containing adipocytes, serve both as storage of fat and as protective padding for organs. 
However, VAT also serves as an endocrine organ in itself, releasing substances such as fat 
free acids and pro-inflammatory proteins (adipokines) affecting other organs and the 
metabolism (53, 54). With excess energy intake the adipocytes will increase in size leading to 
excess release of free fatty acids, hormones, and pro-inflammatory proteins, but also 
structural and cellular changes may occur in the fat tissue as it expands. First, the access to 
blood vessels decrease with the expansion of fat tissue, merely because the distance from 
adipocyte to blood vessels becomes larger (53). This reduced access to blood and oxygen 
leads to hypoxia and further death to the adipocytes. The cell-death further increases the 
releasing of substances from the adipocytes. In addition, as the fat tissue increases it gets 
infiltrated by macrophages, i.e., white blood cells that have the ability to remove dead tissue, 
cells or bacteria. The adipocytes, macrophages and other structures communicate together and 
might even further increase the level of pro-inflammatory proteins. This infiltration of 
macrophages and increased releasing of pro-inflammatory proteins is recognized as one of the 
Figure 2: Abdominal subcutaneous and visceral adipose tissue. Left photo: NIHR BRC 




drivers behind insulin resistance and inflammation. Further, the congestion of macrophages is 
more frequently observed in VAT than in subcutaneous fat (53). The low-grade inflammation 
in the VAT causes damage to other tissues through releasing pro-inflammatory substances 
into the hepatic portal vein (blood vessel transporting blood from the intestines and to the 
liver) which further distributes it to other tissues and organs.  
The high levels of free fatty acids in the bloodstream also affects the lipid metabolism and 
individuals with high amount of VAT often has a distinct lipid profile with, among others, 
high levels of triglycerides and low levels of high-density lipoprotein (HDL) cholesterol (55). 
The higher turnover of triglycerides together with an unhealthy lipid profile again leads to 
potential complications in the blood vessels, increasing the risk for atherosclerosis and heart 
disease. The high levels of free fatty acids in the blood stream and the proximity between 
VAT and organs leads to an increased risk for ectopic fat accumulation. Ectopic fat 
accumulation is storage of fat in the liver, muscles or pancreas and might affect the normal 
function of these organs (55).  
Due to these mechanisms, VAT is associated with hypertension, inflammation, insulin 
resistance, metabolic syndrome, cardiovascular disease and several types of cancer (51). VAT 
is shown to be independently associated with these conditions, even when no associations are 
observed with BMI or waist circumference (50). Several factors can influence amount of 
VAT, and as with other obesity indicators it varies according to sex, age, ethnicity, genetics, 
and hormone levels. Further, lifestyle habits such as diet, physical activity, smoking and 
medication use can influence VAT levels (50, 51). To quantify amount of VAT, one needs 
accurate body composition measure techniques, and no generally accepted reference values or 
thresholds for establishing risk for disease exists. 
  Measurement methods 
There are several methods to assess body composition. Lohman and Milliken (56) have 
ranged the existing methods by their accuracy to determine percentage of fat mass (Figure 3). 
The accuracy of each level is presented as percent: 1% - 2%, 2% - 3%, 3% - 4% and 5% - 6%, 
for level 1, 2, 3 and 4, respectively. The most common and easily available anthropometric 




Figure 3: Level of accuracy of body composition measurements. 
 
Several previous studies have discussed different measures to establish overweight, obesity 
and body composition (57-60). The level of accuracy of the different measures is well 
established, however, certain factors might be important to consider when determining what 
measure to use. One example is the biological changes in body composition with increasing 
age, where muscle mass typically decreases, while fat mass, and in particular VAT mass, 
increases. This concurrent increase in fat mass and decrease in muscle mass, might result in 
stable weight, and might mask potential sarcopenia in the elderly, if the shifting happens 
rapidly (61). Such changes would be difficult to detect with conventional anthropometric 
measures and their accuracy would therefore be poor. Thus, the need for more attention to 
body composition measures, especially in the elderly population, has been advocated (62, 63).  
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Because of its low radiation and high precision, DXA has become a popular tool for 
measuring body composition. DXA is a three compartment model, historically used to 
measure bone mineral content and is currently regarded as the gold standard method for this 
purpose (64). Further, DXA measures the amount of fat mass and lean tissue mass (i.e., 
muscle and other, bone and fat excluded) in addition to presenting tissue composition in 
different areas of the body (i.e., subcutaneous fat and VAT) (Figure 2 and Figure 4) (65). 
DXA-derived VAT is validated to VAT measures from both magnetic resonance imaging 
(MRI) and computed tomography (CT) (66, 67), and is considered an accurate measure of 
VAT. However, the DXA system is expensive and requires location site for storing the 
scanner and performing the measures, trained personnel, and radiation security measures, and 
is therefore not frequently used in everyday clinics. Because it produces significantly less 
radiation-exposure than for example CT it is increasingly included for measuring body 
composition in population studies and other facilities depending on body composition 
measures to ensure effective treatment, such as clinics for osteoporosis and eating disorders. 
While the radiation from CT equals the same amount of natural background radiation 
exposure during several years, the radiation from DXA scans equals natural background 
radiation for less than one day (65). Thus, DXA is far more feasible for frequent or large-scale 
use.  
 
Figure 4: Illustration of DXA-scanner to the left (Photo: The Tromsø Study/Stina 
Grønbech) and DXA-scan images to the right (Photo: NIHR BRC Anthropometry Platform, 
MRC Epidemiology Unit, University of Cambridge) 
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  Rationale for the thesis 
The rationale for this PhD thesis was the observed paradox in high-income countries where 
cardiometabolic risk factors have decreased while prevalence of overweight and obesity 
continue to increase. This inverse association is unexpected because of the well-established 
association between obesity and cardiometabolic health described above. Because obesity is 
most frequently measured by BMI and waist circumference, which does not distinguish 
between fat mass and muscle mass, we questioned whether BMI and waist circumference 
actually represents what the definition of obesity is meant to capture. We hypothesized that 
VAT would be a more accurate measure than BMI or waist circumference to address 
risk of cardiometabolic disease, and that the time trends for total fat and VAT might not 
correspond to those observed by anthropometric measures.   
Because most risk factors, diseases and mortalities attributed to obesity are of cardiometabolic 
character, and because MetS includes several risk factors for cardiometabolic disease, we 
used MetS and single components of MetS to establish risk for cardiometabolic disease in the 
current thesis and to examine whether prevalence and risk of MetS differs according to 
different obesity measures. Lastly, because it is well established that VAT is more 
metabolically harmful and more strongly related to disease than other fat tissue, it was 
considered important to determine whether measures of VAT is necessary for accurately 




2 Aims of the thesis 
The overall aims of this thesis were to obtain knowledge and insights about population body 
composition and to explore reference values of DXA-derived VAT, its correlation with 
cardiometabolic health and traditional overweight measures and time trends. We used the 
comprehensive population-based Tromsø Study which contains repeated surveys with 
detailed information about both body composition and cardiometabolic health.  
Thus, the specific aims were to: 
1. Establish reference and threshold values for VAT (absolute and relative units) in 
adults and elderly and investigate whether different measurement units of VAT 
differed in their association with cardiometabolic risk factors and MetS. 
 
2. Investigate correlations between VAT and commonly used anthropometric measures 
(BMI, waist circumference, WHR, and WHtR), and further investigate and compare 
their association with cardiometabolic risk and MetS.  
 
3. Investigate secular and longitudinal trends in body composition (fat, lean and VAT 


































3 Material and methods 
 The Tromsø Study 
Tromsø municipality is located in the north of Norway above the Arctic Circle, with a current 
population of 77 000 inhabitants. Tromsø has both urban and rural settlements and is similar 
to the general population in Norway according to sex and age (68). In the 1970ies the 
prevalence of cardiovascular disease in the North of Norway was higher than in the rest of the 
country, and especially high in men. To understand the causes behind the higher prevalence of 
cardiovascular disease, the Tromsø Study was initiated, with the first data collection in 1974. 
Since then, a total of seven surveys have been conducted to date (Tromsø 1 1974, Tromsø 2 
1979-1980, Tromsø 3 1986-1987, Tromsø 4 1994-1995, Tromsø 5 2001, Tromsø 6 2007-
2008, and Tromsø 7 2015-2016), inviting whole birth cohorts and random samples of women 
and men in various age-groups, and continuously increasing in amount of data and 
information collected. The history and description of the Tromsø Study (survey 1-6) is 
thoroughly described elsewhere (69-71) and the seventh survey, together with questionnaires, 
are presented at the Tromsø Study webpage (72). Data collection has included questionnaires 
and interviews, biological sampling, and clinical examinations. From Tromsø 4 and onwards, 
more extensive clinical examinations were added, and each survey included two separate 
visits: 
• The first visit consists of a basic examination for the total study sample. Data 
collections include questionnaires with (among others) questions about health, 
lifestyle, family health history and social relationships, examinations including 
(among others) measurements of anthropometry and blood pressure, and biological 
samples collected for analysis of (among others) blood lipids and glycated hemoglobin 
(HbA1c).  
• The second visit consists of extended examinations for a subsample. The subsample is 
a pre-defined sub-sample of the total invited sample. Data collections include (among 
others) additional biological sampling, electrocardiography, echocardiography, carotid 
artery ultrasound, eye examinations, lung function tests, physical function tests, 
cognitive function tests, accelerometry, and body composition measurements (DXA). 
The information collected during the second visit has continuously been expanded 
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over time, thus not all the listed examinations has been included since Tromsø 4 but 
were included in later surveys.  
3.1.1 The study sample  
In Tromsø 5 (2001) 10 324 women and men aged 30 years and older living in Tromsø 
municipality were invited to participate. The invited sample consisted of two groups: 1) 
participants attending extended examinations in Tromsø 4 (n= 6961) and 2) participants 
attending the Norwegian Institute of Public Health’s (NIPH) National health survey (n= 3363) 
(73). A total of 8130 women (57%) and men aged 30-89 years participated (89% from the 
first group, and 57% from the second [NIPH] group). The participants attending the basic 
examinations that also attended the extended examinations in Tromsø 4 were all invited to 
extended examinations in Tromsø 5. A total of 5952 attended the extended examinations, of 
which 1713 had valid total-body DXA scans. 
In Tromsø 6 (2007-2008) 19 762 women and men living in Tromsø municipality were invited 
to participate. The invited sample consisted of four different groups: 1) all inhabitants aged 
40-42 years or 60-87 years in the Tromsø municipality (n= 12 578), 2) a 10% random sample 
of inhabitants aged 30-39 years (n= 1056), 3) a 40% random sample of inhabitants aged 43-59 
years (n= 5787) and/or 4) participants attending the extended examinations in Tromsø 4 
(1994-1995) (n= 341) (74). A total of 12 984 women (53%) and men aged 30-87 years 
participated (66% of the originally invited sample). Of the 12 984 participants attending the 
basic examinations, the following was invited to extended examinations: all participants also 
attending extended examinations in Tromsø 4, all participants aged 50-62 years or 75-84 
years, and a 20% random sample of participants aged 63-74 years. A total of 7307 attended 
the extended examinations, of which 906 had valid total-body DXA scans. 
In Tromsø 7 (2015-2016), all inhabitants 40 years and older living in Tromsø municipality 
were invited to participate (n= 32 591) (75). A total of 21 083 women (53%) and men aged 
40-99 years participated (65% of the originally invited sample). Of the 21 083 participants 
attending the basic examinations, a pre-defined sample (marked before attending basic 
examinations) of 13 028 participants from two groups were invited to extended examinations: 
1) a random sample of the invited participants to Tromsø 7 (n= 9925), and 2) participants 
attending DXA, echocardiogram and eye examinations in Tromsø 6 (n=3103). A total of 8346 




In each survey DXA scans were performed with a GE Lunar Prodigy Advance (GE 
Healthcare Medical Systems, Madison, Wisconsin) as a part of the extended examinations. 
DXA-derived body composition measurements have been collected in the Tromsø Study 
since Tromsø 5 (2001). A predefined subsample of those pre-marked for the extended 
examinations were examined by DXA. Thus, not all invited to extended examinations were 
pre-defined for DXA-examination. Information to the extended examinations included 
instruction to wear light clothing. Before the DXA scan, the participants were asked to 
remove all metal objects (jewelry etc.). Special clothes were available for use during the scan 
if necessary (to avoid metal in clothes). No instructions were given regarding food- or water 
intake, or regarding physical activity before attending the scanning. The DXA scans were 
performed by trained technicians, who had received standard operating procedures about 
performing DXA scans according to the manufacturer’s guidelines. Each morning the DXA 
system was calibrated with a standard phantom as recommended by the manufacturer. Post-
scanning inspection of images and region of interest (ROI) adjustment was performed 
according to the manufacturer’s guidelines. To standardize VAT analyses, the upper 
horizontal ROI separating the torso and the head was positioned below the lower boundary of 
the chin bone. The variables included from DXA scans measurements in the three papers are 
described below. 
3.1.2 Paper Ⅰ and Paper Ⅱ study sample and variables 
Sample 
In paper Ⅰ and paper Ⅱ we included the 3675 participants with valid total-body measures from 
DXA scans in Tromsø 7 (Figure 5). The included sample consisted of 2152 women and 1523 






Figure 5: Inclusion of participants in paper Ⅰ and paper Ⅱ 
 
Variables 
In paper Ⅰ and paper Ⅱ we included information about age, sex, weight, and height, 
cardiometabolic risk factors and DXA-derived VAT (absolute and relative units). Self-
reported information about diabetes (Do you have, or have you had diabetes? "No", "Yes, 
now", "Yes, previously") and medication-use ("Do you use, or have you used blood pressure 
lowering drugs?", "Do you use, or have you used cholesterol lowering drugs?", "Do you use, 
or have you used insulin?", and "Do you use, or have you used tablets for diabetes?", all with 
answer alternatives "Currently", "Previously, not now" and "Never used") was included. 
Blood pressure (systolic and diastolic blood pressure [mmHg]) was measured three times with 
two-minute intervals measured with a Dinamap ProCare 300 monitor (GE Healthcare, 
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Norway) and the mean reading from the two last readings was used. Further, we included 
information about triglycerides (mmol/L), total cholesterol (mmol/L), HDL cholesterol 
(mmol/L), HbA1c (%) and C-reactive protein (mg/L). Because only non-fasting blood 
samples were available, we could not create a MetS variable identical to the NCEPT ATP Ⅲ 
(37) criteria, but we created a modified version of MetS based on the NCEPT ATP Ⅲ: 
hypertension (systolic blood pressure >130 mmHg and/or diastolic blood pressure >85 mmHg 
and/or current use of antihypertensives), high non-fasting triglycerides (triglycerides ≥1.7 
mmol/L and/or current use of lipid-lowering drugs), low HDL cholesterol (HDL cholesterol 
<1.3 [women] or <1.0 [men] mmol/L and/or current use of lipid-lowering drugs) and diabetes 
(self-reported current diabetes and/or HbA1c ≥6.5% and/or current use of antidiabetics). MetS 
(presence of three or more of the MetS components) based on the NCEP ATP Ⅲ criteria was 
included in both papers. Among the 3675 participants with valid VAT measures information 
about prevalence of hypertension, high triglycerides, low HDL cholesterol and diabetes had 
percentage missing data ranging between 1-3%, and 4% missing for prevalence of MetS.  
From the DXA scans information about total body fat (grams and percentage) and VAT mass 
(grams and volume) were included. Further, information about total body fat mass in the 
android region was included to enable for calculation of percent VAT in the android region 
(100*VAT mass/android fat). Index of VAT mass was calculated as VAT mass/height m2. 
Relative measures of VAT were considered to be important because it is expected that larger 
persons (in regard to muscles or height) will have a larger amount of VAT mass, compared to 
a smaller person although the smaller person can have a more unhealthier VAT mass relative 
to body size.  
In paper Ⅱ, information about anthropometric measures (BMI [n= 3682], waist circumference 
[n= 3666], WHR [n= 3666] and WHtR [n= 3664]) were also included for the purpose of 
comparing VAT mass (grams) to anthropometric measures.  
3.1.3 Paper Ⅲ study sample and variables 
Sample  
In paper Ⅲ, we aimed to present both longitudinal and secular trends in DXA-derived body 
fat, VAT mass and lean mass from Tromsø 5 in 2001 to Tromsø 7 in 2015-2016. Therefore, 
participants with valid total-body DXA scans from Tromsø 5, Tromsø 6 and/or Tromsø 7 
were included (Figure 6). Participants younger than 40 years in Tromsø 5 and Tromsø 6 were 
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excluded (because they were few, n=51 and n=5, respectively). Initially, in Tromsø 5 a total 
of 1726 had total-body DXA scan measures, but 13 participants did not give consent and were 
not included in the data. Therefore, a total of 1662 (62% women), 901 (63% women) and 
3670 (59% women) participants from Tromsø 5, 6 and 7, respectively, had measures for body 
fat mass and lean mass. We did not have complete repeated measures for all included 
participants. A total of 940 participants attended two or more of the three surveys, of which 
382 attended all three. Both fat mass and lean mass were derived with Basic Mode analysis to 
harmonize between all three surveys. The EnCore software (version 17.0, GE Healthcare, 
Madison, Wisconsin) was used for extracting data at the three surveys. In 2010, a new 
application (CoreScan) to the software enabled for calculation of VAT mass. Thus, the stored 
images were re-analyzed in 2019 and VAT mass measures were extracted from all three 
surveys. Amount of VAT mass is not directly measured during DXA scanning but estimated 
by subtracting subcutaneous fat mass from total android fat mass. Not all stored raw images 
from Tromsø 5 were available for re-analyzation (images not found). Thus, in Tromsø 5, 
VAT measures were only available from 284 (65.2% women) participants. Further, 
information about android fat mass was not available from Tromsø 5, thus we were unable to 
estimate proportion of VAT mass from Tromsø 5. From Tromsø 6, all participants with total 
body fat and lean mass measures, also had valid VAT measures (n=901). From Tromsø 7, 
VAT images from an additional 5 participants (in addition to the 3670 participants with valid 
measures of total body fat mass and lean mass) were available.  
Therefore, from Tromsø 7, there were 3670 total body fat and lean mass measures, and 3675 
available VAT mass measures. Further, 2 participants from Tromsø 7 with VAT percent 
above 100% were excluded from all analysis of VAT, leaving 3673 participants from Tromsø   








The Tromsø Study is performed in accordance with the 1964 Helsinki declaration and its later 
amendments. All participants gave written informed consent. Data from participants that had 
withdrawn their consent was excluded prior to data delivery from the Tromsø Study. This 
PhD project was approved by the Regional Committee for Medical Research Ethics (REC 
North ref. 2017/1967). 
 Statistical analyses 
Paper Ⅰ  
In paper Ⅰ we used descriptive analyses to examine the distribution of VAT presented as 
different units (grams, index, and %) and further created reference values for the different 
measurement units of VAT mass in 10-year age groups for women and men, separately. VAT 
volume (cm3), which is also available from the DXA scans, were analyzed, but all results 
were close to identical to that of VAT grams and were therefore excluded from the paper. 
Descriptive analyses were used to present quantiles (5th, 25th, 50th, 75th and 95th) of VAT 
(grams, index, and %) in 10-year age-groups. Receiver operating characteristics (ROC) curve 
analysis were used to examine if VAT in different units (grams, index, and %) differed in 
association with MetS and the single MetS components, separately. To examine whether 
different units of VAT (grams, index, and %) showed different associations with MetS and 
single MetS components, we transformed the VAT measures by square root and subsequently 
created z-score units for all three units. It was necessary to standardize the different units to 
enable for comparison between them in regression analysis. Thereafter, we used logistic 
regression to present the association between z-scores of VAT and MetS and single MetS 
components in groups of BMI (normal weight, overweight, and obese). ROC analysis was 
also used to derive sensitivity and specificity for VATs prediction for MetS. We then used 
highest value of Youden’s index ([sensitivity + specificity]-1) to create thresholds for VAT 
(grams, index, and %) (76, 77). Lastly, we used logistic regression to present the odds for 





In the second paper descriptive analysis was used to present demographics of the study 
population. We calculated Pearson’s correlation coefficient between VAT mass (grams) and 
more commonly used anthropometric measures (BMI, waist circumference, WHR, and 
WHtR) in 10-year age-groups. ROC curves and c-statistics were used to present and compare 
the predictive abilities of VAT mass, BMI, waist circumference, WHR, and WHtR for MetS 
and single MetS components (hypertension, diabetes, high triglycerides, and low HDL 
cholesterol).  
Paper Ⅲ  
In paper Ⅲ we analyzed both the secular trends and the longitudinal trends in fat mass, VAT 
mass, and lean mass from Tromsø 5 (2001) to Tromsø 6 (2007-2008) and further to Tromsø 7 
(2015-2016). Both absolute values and proportions of fat mass, lean mass, and VAT mass 
(proportion of VAT mass was only available from Tromsø 6 and Tromsø 7) were examined. 
Descriptive analysis was used to present study characteristics of participants attending only 
one of the surveys and for those attending two or more surveys. Descriptive analyses were 
also used to present mean values of fat mass, VAT mass, and lean mass in 10-year age-groups 
in women and men in the three surveys (Tromsø 5, Tromsø 6, and Tromsø 7). Kernel density 
plots were used to examine the distributions of fat mass, VAT mass, and lean mass in the 
three surveys. To examine the longitudinal trends, we used age adjusted/birth year adjusted 
generalized estimation equation. To investigate potential age-group differences in longitudinal 
trends we included interaction terms as two-way cross-product terms between indicator 
variables of 10-year age-groups (40-49, 50-59, 60-69 and 70-79) and an ordinal variable of 
time (Tromsø 5, Tromsø 6, and Tromsø 7). The age-groups were used to represent birth 
cohorts and will be addressed as birth cohorts in the rest of the thesis. Because we did not 
have repeated measures for all participants, we performed separate analyses for both those 
who attended two or more surveys (n=940) as well as for those who attended all three surveys 
(n=382).  









4 Results – summary of papers 
 Paper Ⅰ: Reference values for DXA-derived visceral adipose tissue 
in adults 40 years and older from a European population 
A total of 3675 women and men with DXA-derived VAT measures (grams, index, and %) 
were included. Mean age was 66.2 years in women and 65.9 years in men. When comparing 
participants attending DXA scans with participants not invited or not attending DXA scans 
we found that the DXA attenders had lower weight and height, and men attending DXA had 
slightly lower BMI (27.9 and 27.6 kg/m2, respectively) while no differences were observed in 
waist circumference. VAT (grams, index, and %) was higher in men than women and was 
positively associated with age up to 70 years. All findings for VAT as grams or index were 
highly similar. VAT% increased steadily in women (all ages), while it flattened after age 70 
in men. This continued increase in VAT% after age 70 in women is explained by the 
relationship between the slightly decreasing absolute VAT mass relative to the steeply 
decreasing subcutaneous fat mass in this age-group. VAT (all measurement units) was 
positively associated with cardiometabolic risk factors. VAT in grams and in index were 
stronger predictors of MetS and single MetS components than percentage of VAT. Logistic 
regression analysis of z-score units of VAT showed, overall, that increasing VAT increased 
the odds for all single MetS components and MetS. In analysis in categories of BMI there was 
no linear association, meaning that z-scores of VAT (all measurement units) in association to 
MetS components were not continuously stronger in higher categories of BMI. The thresholds 
according to the Youden’s index presented were ≥1134 and ≥1859 grams, ≥0.44 and ≥0.55 
index, and ≥40.3 and ≥61.2 %, in women and men, respectively, and are suitable for 





 Paper II: Anthropometric measures are satisfactory substitutes 
for the DXA-derived visceral adipose tissue in the association with 
cardiometabolic risk  
In paper II, a total of 3675 participants were included. Mean age was 66.2 and 65.9 years in 
women and men, respectively. Men had higher mean VAT values and higher mean values of 
the anthropometric measures compared to women. The sample mean BMI value was similar 
to what is considered as being in the overweight category, while mean waist circumference 
levels were similar to having very high risk, or high risk for cardiometabolic disease in 
women and men, respectively. VAT was moderately to strongly associated with all 
anthropometric measures, although the correlations were slightly lower in women than men 
and in the older age groups. The correlation was strongest between VAT and waist 
circumference (r: 0.69-0.84 and 0.79-0.88 in women and men, respectively) and weakest 
between VAT and WHR (r: 0.43-0.64 and r: 0.63-0.72 in women and men, respectively). 
AUC’s showed that both VAT and the anthropometric measures were strong predictors for 
MetS and single MetS components, and although c-statistics revealed that VAT was 
statistically a stronger predictor than the anthropometric measures, the AUCs were close to 
identical (e.g., AUC’s for MetS in women were 0.728 for VAT versus 0.693 for BMI). In 
women, VAT was statistically stronger than BMI and waist circumference for prediction of 
diabetes, high triglycerides, low HDL and MetS. Compared to WHR, VAT was statistically 
stronger in prediction of high triglycerides, and statistically stronger than WHtR in prediction 
of high triglycerides, low HDL cholesterol and MetS. In men, VAT was statistically stronger 
than BMI and waist circumference in prediction of all MetS components and MetS, and 
statistically stronger than WHR and WHtR in prediction of MetS and all MetS components 
with the exception of diabetes. However, because all AUC’s were high, and very similar 
between the anthropometrics and VAT, we concluded that the anthropometric measures were 
satisfactory substitutes for VAT.  
When using ROC analysis to examine which of the anthropometric measures that was the best 
predictor for VAT, the strongest AUC’s was observed for waist circumference (AUC: 0.90), 





 Paper Ⅲ: Secular and longitudinal trends in body composition 
In paper Ⅲ a total of 1662 participants (62% women) from Tromsø 5, 901 participants (63% 
women) from Tromsø 6 and 3670 participants (59% women) from Tromsø 7 with fat mass 
and lean mass measures are included. Information about VAT mass was available for 284, 
901, and 3673 participants from Tromsø 5, Tromsø 6 and Tromsø 7, respectively. The mean 
age was slightly higher in Tromsø 6 (68.5 and 69.9 years in women and men, respectively) 
than in Tromsø 5 (65.2 and 66.5 years in women and men, respectively) and Tromsø 7 (66.7, 
and 66.2 years in women and men, respectively). When examining potential differences in 
cardiometabolic risk factors between those attending one of the surveys and those that 
attended two or more surveys, we found only small, clinically minor differences.  
Body fat and VAT mass increased from 2001 to 2015-2016, with a more pronounced increase 
from 2007-2008 to 2015-2016, than from 2001 to 2007-2008. Women had higher fat mass 
than men in all three surveys, and men had higher VAT mass across all three surveys than 
women had. Further, VAT mass increased at a higher rate across the three surveys in men 
than women. Longitudinal trends showed that the increase over time in fat mass and VAT 
mass across the surveys was most pronounced in the younger birth cohorts (40-49 years in 
2001, particularly in women). This differences in fat and VAT mass changes between birth 
cohorts was, however, only significant in women.  
Total lean mass was higher in men than women in all three surveys and remained unchanged 
from 2001 to 2015-2016. Lean mass in percent (relative to total fat and bone mass) did, 
however, decrease across surveys, with a larger decrease between 2007-2008 and 2015-2016 
than between 2001 and 2007-2008. This reflects the larger increase in absolute fat mass 
compared to the smaller changes in absolute lean mass. 
Sensitivity analysis including those attending two or more surveys, or those attending all three 
surveys, showed similar results to that observed in the main analysis (including all 










The main aims of this thesis were to examine VAT in a general population, both regarding 
associations with cardiometabolic risk factors and associations with more commonly used 
anthropometric measures. Further, the aim was to examine the trends in body composition 
over time in a general population. Given that there is no consensus regarding reference, 
threshold, or preferred unit of DXA-derived VAT in population studies, our first objective 
was to thoroughly examine both absolute and relative measures of VAT in a general 
population to determine whether any of them showed stronger associations with MetS and/or 
single MetS components. Both absolute and relative measures showed similar associations 
with MetS, but VAT in grams and index were highly comparable and had slightly stronger 
coefficients than percentage of VAT. We further created threshold values for VAT (grams, 
index and percent) based on sensitivity and specificity in prediction of MetS and showed that 
VAT mass beyond these thresholds increased the odds for MetS by 3-4 times. In comparison 
with more traditionally used anthropometric measures such as BMI, waist circumference, 
waist-to-hip ratio and waist-to-height ratio, VAT was a statistically better predictor for MetS, 
although visual comparison of results indicated small clinical differences. Finally, both 
longitudinal and secular trends in VAT mass and body fat increased from 2001 to 2015-2016 
with a larger increase between 2007-2008 and 2015-2016 and in the youngest birth-cohort 
(aged 40-49 in 2001, significant only in women). We believe our results are valuable 
contributions to the obesity and body composition research field, but that our study also has 
limitations and areas in need for caution when interpreting the results. Thus, methodological 
considerations will be addressed and discussed before a more general discussion of results, 
implications, and considerations for the future.  
 Methodological considerations 
5.1.1 Internal validity 
In the Dictionary of Epidemiology by Miquel Porta (78, p.287) validity is defined as “the 
degree to which inferences drawn from a study are valid”. Thus, it is a consideration of how 
trustworthy or reliable the results are, either in relation to what is measured in the study 
sample (internal validity, i.e., VAT in association with MetS) or whether the results and 
findings are applicable/generalizable to the general population beyond the study sample 
(external validity).  
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Internal validity is defined as “the degree to which a study is free for bias or systematic 
error” (78, p. 287). It refers to whether the design of the study, collection of data and 
analyses are satisfactory for answering the initial aims of the study. Thus, internal validity is a 
necessity for extrapolating the results from a study into external validity or generalizability 
(described below in section 5.1.6). Internal validity can be influenced by factors such as study 
design, bias/systematic error, confounding factors and statistical approaches (78). Because 
there is always a risk of bias and confounding factors in epidemiological studies, it is 
important to acknowledge and discuss the potential limitations. In the following sections, 
internal validity is considered an umbrella term, which covers important aspects and 
limitations addressed under the different headings considered most relevant for internal 
validity in the current thesis. 
5.1.2 Study design 
The Tromsø Study is an ongoing population-based cohort study inviting total birth cohorts or 
random samples from the general population and contains relevant information to address the 
aims presented in this thesis.  
In paper Ⅰ and Ⅱ, we chose a cross-sectional design from where all information is collected at 
one point in time (2015-2016). For paper Ⅰ, where we aimed to create reference and threshold 
values for VAT, we wanted the most recent data because the population characteristics are 
continuously changing. However, I acknowledge that a prospective cohort study is the best 
design to examine the association between VAT (absolute and relative units) and MetS, as a 
cross-sectional design make causal inferences impossible because one cannot show directions 
of associations. This consideration also applies to paper Ⅱ where we chose a cross-sectional 
design to examine how well VAT correlated with the more commonly used anthropometrics. 
This was considered a valid approach both because we wanted to present recent data (as in 
paper Ⅰ), but also because the anthropometric measures of overweight have increased over 
time, which could potentially affect the correlation between VAT and these measures. Again, 
if the aim had been to show which of the measures that caused MetS, we would need a 
prospective design. I acknowledge that the use of the word “predicted” in paper Ⅱ when 
addressing the association between different overweight measures and VAT might cause 
confusion because to predict an outcome based on an exposure would require a study design 
where causal effects could be shown. However, the word “predict” was used based on the 
statistical method applied (ROC curve analyses), which estimated predicted probabilities (79). 
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Although the prospective cohort design is superior to a cross-sectional design in establishing 
causal relationships, the cross-sectional design was considered satisfactory to answer the aims 
in paper Ⅰ and Ⅱ, which were not to examine causal pathways, but to create reference- and 
threshold values for VAT based on the most recent measures, and to examine correlations 
between VAT and anthropometric measures at a given point in time. The findings are 
valuable to generate hypotheses for future studies investigating potential causal pathways 
between VAT and MetS.  
In paper Ⅲ, we chose a longitudinal design, together with analyses of secular trends in body 
composition. The definitions of both longitudinal and secular trends, together with challenges 
associated to these designs are more thoroughly described below in section 5.1.7 
(Longitudinal studies: effect of cohorts and time). The longitudinal design allows us to 
describe time-trends in whole populations and population sub-groups, such as cohorts or age-
groups. This design, together with the statistical methods (GEE) described below, was 
considered an appropriate approach to both examine the secular- and longitudinal trends in 
fat-, lean- and VAT mass in the Tromsø Study.  
5.1.3 Selection bias  
There are three subcategories to selection bias; population bias, response bias and Berkson’s 
bias, from where the most relevant subcategories for this study are the two first (80). 
Population bias refers to sampling and choice of study population and response bias refers to 
the response of invited participants (80). 
In the Tromsø Study, historically, the invited participants were selected for the purpose of 
investigating specific risk factors for a given disease. For example, in the first survey in 1974, 
only young and middle-aged men were invited and there was a focus on cardiovascular 
disease because the mortality of these diseases in men then was particularly high in northern 
Norway. However, in the fourth survey in 1994-1995, all inhabitants aged 25 years or older 
were invited, and since then there has been a more general invitation of participants within a 
wider age range (72). The Tromsø Study aims to re-invite previous participants to enable for 
follow-up, but also to invite new participants in order to, among other things, reduce the risk 
of selection bias. In paper Ⅰ and paper Ⅱ, participants from the extended examinations in the 
seventh survey of the Tromsø Study were included. In Tromsø 7 all women and men 40 years 
and older living in Tromsø municipality were invited to participate. Both a randomized pre-
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marked sample of the originally invited participants, together with participants that attended 
extended examinations in Tromsø 6, were invited to visit 2 (extended examinations, including 
DXA scans). Thus, although bias attributed to differences between attenders and non-
attenders might still exist, the risk of selection bias due to a particulate population being 
invited is limited. Potential bias caused by differences between non-attenders and attenders is 
difficult to avoid, because participation is voluntarily. Participants attending population 
surveys are often different from the non-attenders in regard to more favorable health status 
(81-84), higher socioeconomic status (82, 83, 85) and overall lower mortality (70, 81-83, 86-
88). Statistical analyses can be used to compare attenders and non-attenders according to 
certain characteristics, like age and sex, but the lack of additional information makes it 
complicated to assume generalizability without discussing these limitations thoroughly.  
In paper Ⅰ, we observed a decrease in VAT after the age of 70. This was surprising because 
usually, the abdominal fat increases with increasing age. These age-dependent findings after 
age 70 might be affected by selection bias or survival bias. The attenders aged 70 years and 
older might be the healthiest representatives for this age-group as those with less favorable 
health might be unable to attend due to health complications. If this is the case, the result is a 
highly selected group of participants from the elderly, comprising the healthiest in this 
population. This might explain the observed decrease in VAT in those 70 years and older.  
In paper Ⅰ the results are sensitive to selection bias, because the reference- and threshold 
values presented reflect the amount of VAT in the included participants and their prevalence 
of MetS. Thus, if the participants are in better health or have lower VAT than non-attenders, 
the presented reference- and threshold values are only applicable to populations similar to the 
participants in regard to amount of VAT and prevalence of MetS. In paper Ⅱ we compared 
VAT with the anthropometric measures. With this purpose the potential effects of selection 
bias are less worrisome unless the correlation between body composition and the 
anthropometric measures differs between attenders and non-attenders. There is, however, 
little reason to believe that there are large differences in these relationships between attenders 
and non-attenders. 
In paper Ⅲ, we included all participants that attended DXA during the second visit (extended 
examinations) in Tromsø 5, Tromsø 6, or Tromsø 7. In Tromsø 5, the invited sample to the 
second visit (extended examinations) consisted of 6185 participants attending the first visit in 
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Tromsø 5 (who had also attended the second visit in Tromsø 4). In Tromsø 6 the invited 
sample to the second visit (extended examinations) consisted of 1) all participants from the 
first visit in Tromsø 6 also attending extended examinations in Tromsø 4, 2) all participants 
from the first visit in Tromsø 6 aged 50-62 years or 75-84 years, and 3) a 20% random sample 
of participants from the first visit in Tromsø 6 aged 63-74 years (72). The re-invitation of 
previous participants might lead to selection bias because of the health profile differences 
between non-attenders and attenders described above (70, 81-88). If the participants included 
in our papers are in better health than the rest of the population, it is likely to assume that they 
have both lower VAT and lower prevalence of MetS, which would result in lower external 
validity of our results. One of the basic ideas behind epidemiological research is to monitor 
and understand risk factors and outcomes in populations (89), in addition to observing 
potential changes in these factors. Therefore, disregarding potential selection bias, it is 
important to also invite previous attendants to enable for longitudinal studies.  
The results from paper Ⅲ are also potentially subject to selection bias. The GEE analysis 
estimates values for the missing participants at each time point, but these estimates are created 
based on existing data and trends in the sample. Therefore, if non-attenders have higher VAT 
than attenders, the presented trends may only apply to the populations similar to the attenders, 
thus limit generalizability. Essentially, the prospective population-based cohort design of the 
Tromsø Study is exposed to potential differences in attenders and non-attenders. Therefore, 
potential differences should always be discussed in the light of external validity, even though 
the Tromsø Study has a relatively high attendance (65%-79% in the relevant time, compared 
to for example the Norwegian HUNT Study where the response was 54% in HUNT 3, 2006-
2008 (90)).  
5.1.4 Information bias and self-reported measures 
Porta et al., (78, p. 149) defines information bias as “A flaw in measuring exposure, 
covariate, or outcome variables that results in different quality (accuracy) of information 
between comparison groups”. Epidemiological research is depending on measures. In the 
Tromsø Study, measures are collected repeatedly over time, and all these measures are 
potentially influenced by error. This error in measurements might result in information bias. 
Thus, information bias is an important concept to consider in population studies that often 
contains a large number of variables collected through different measures. Frequently used 
tools for collecting information are questionnaires (self-reported by the participants, with or 
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without the use of validated instruments), measures conducted by trained technicians (for 
example weight and height measured with standard protocols and calibrated devices) and 
biomarkers (for example analysis from blood samples performed with standard methods at 
accredited laboratories). Thus, information bias might influence internal validity.  
Measurement error and misclassification 
Before going deeper into the potential measurement errors occurring in this thesis, some 
clarifications of definitions are needed. When discussing error and bias there are several terms 
that address the same challenges, which might lead to confusion. Bias is defined by Porta et 
al, (78, p. 21) as “systematic deviation of results or inferences from the truth”. The term 
systematic error refers to skewness of estimates or results in the same direction whereas 
random error is non-systematic errors (going in both directions) in estimates or results (91).  
Further from this, differential error is when the occurrence of measurement error differs in 
different groups (e.g., women and men). 
Both systematic and random measurement error can occur at many stages during the study; 
during designing of the questionnaire for self-reported data, personal beliefs, and 
characteristics of the study participants, it can be influenced by the study technicians (i.e., the 
technicians performing the DXA scans or measuring waist circumference), or limitations of 
the actual tools used to collect information (the DXA scanner or the measurement tape).  
Further, measurement error can be present at different levels, on a single variable or in 
association between variables leading to different effects on the outcome. On a single variable 
level, a systematic error will have consequences for the mean value of that variable, but also 
for prevalence, if that variable is used to classify the participants. An example of systematic 
error at variable level could be blood pressure measurement where the measurement tool is 
not accurate, leading the blood pressure to be consistently wrongfully measured in one 
direction (i.e., 10 mmHg higher than the actual blood pressure). This would lead the mean 
level of blood pressure in the participants to be higher than in reality, and the prevalence of 
participants with hypertension will be overestimated. If there is random error in the blood 
pressure measures, occurring from e.g., some participants having higher blood pressure 
measures than in reality (due to e.g., sneezing) while others having lower blood pressure 
measures (due to e.g., sleeping), the mean blood pressure in the participants might not be 
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affected, nor the prevalence of hypertension. In the current thesis, measurement error on a 
single variable level might have affected the prevalence of participants classified as having 
MetS. 
Measurement error occurring when examining the association between variables might affect 
the observed association, depending on whether the measurement error in one variable is 
dependent on the other variable at interest. If the measurement error in one variable is not 
depending on another variable the error is non-differential and the association between the 
two will usually be weakened. An example could be that technicians accidentally measuring 
waist circumference inaccurate in both participants with and without obesity (some measures 
lower and some measures higher than actual waist circumference). Because this error can go 
in either direction in both participants with and without obesity, it is non-differential, but 
increases the uncertainty of the results and might hide potential associations between the 
variables (i.e., waist circumference and obesity) (91, p. 105).  
On the other hand, if measurement error in one variable depends or differs depending on 
another variable it is called differential error (misclassification) and can lead to false 
associations (positive or negative) between these two variables (89). Differential error distorts 
the results in a given direction. A typical example is how mothers of children born with 
disease are more likely to remember and report their behaviours during pregnancy than 
women with healthy born babies. Thus, having a diseased child will seem to be associated 
with more reported risk factors, but in reality, it is just because these women report their 
behaviour more thoroughly. Examples of differential misclassification from the current thesis 
could be if the study technicians consistently measured waist circumference in a different area 
in participants with obesity than in participants with normal weight, leading to an over- or 
underestimating of waist circumference with a consistent error (for example 4 cm larger) in 
the participants with obesity. Another example, relevant for classification of the MetS criteria, 
is blood pressure measurements. If the study technicians failed to follow the study protocol 
and measured participants blood pressure just after they had climbed the stairs to the research 
site, the increase in blood pressure because of this protocol deviation might be higher in 
participants with obesity compared to participants with normal weight (although they would 
all have higher measures than their actual blood pressure at rest). In this case, more 
participants would be classified as being hypertensive among those with obesity, and further 
as having MetS. 
38 
 
In paper Ⅰ and Ⅱ the participants were classified as having MetS if three or more of the single 
components (hypertension, diabetes, high triglycerides or low HDL cholesterol) were present. 
Please note that we have created a modified version of the NCEP ATP Ⅲ MetS criteria from 
Figure 1, where waist circumference was excluded as we aimed to compare associations with 
VAT and waist circumference as well as anthropometric measures that are all highly 
correlated with waist circumference. The MetS criteria included self-reported information 
(like diabetes and medication use) and objective measures (biological samples such as 
triglycerides). Misclassification of MetS might occur due to systematic or random 
measurement error in either of the included variables in the MetS criteria. This could alter our 
results in either direction depending on whether more cases were classified as having MetS 
among participants with higher or lower amount of VAT. If the MetS variable included a 
large number randomly misclassified cases the associations with VAT and anthropometric 
measures will most likely be weakened (80). However, random error is often more subtle and 
difficult to discover than systematic error, partly because mean values might remain the same 
in continuous variables, but also because the misclassification will go in both directions 
(equal distribution of wrongfully misclassified participants as having and not having MetS).  
To minimize the risk of measurement error, all surveys of the Tromsø Study have included 
standard operating procedures for all measures performed (e.g., weight, height, waist 
circumference, blood pressure and DXA scans). All technicians are trained in accordance with 
the same protocol. Thus, measures have been taken to limit the risk for both random and 
systematic measurement error. However, there is always a possibility that errors might still 
occur. 
Measurement error of the DXA-system 
Two main DXA-systems manufacturers exists today; Hologic and GE Healthcare. GE 
Healthcare produce the Lunar Prodigy and the Lunar iDXA. The Lunar Prodigy scanner is 
used for addressing body composition and VAT in the current thesis. Findings and results 
across different scanners and systems are not directly comparable. Nor are results between 
different populations because the results are expected to differ due to differences in data 
extrapolation and software between different manufacturers. However, continuous software 
improvements enable future comparison between DXA scanners from the same manufacturer 
and the possibility of extrapolating more advanced data. The Lunar prodigy scanner was 
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supported by Enhanced Analysis mode, a method for extrapolating data that enables for 
comparison with the newer Lunar iDXA scanner, which initially provides higher resolution 
images. Further, updated software applications such as the CoreScan software EnCore version 
17.0 enables for extrapolation of data such as VAT measures. While newer systems and 
software have improved the imaging and body composition estimation from DXA (67), 
measurement errors can occur before, during or after the scans.  
Firstly, measurements can be affected by factors occurring pre-scan. The DXA system 
requires trained technicians in addition to standard guidelines or protocols. The manufacturer 
(GE Healthcare) has created standard guidelines including information such as cautions and 
safety instructions, standard operating procedures, and general information. In accordance 
with the manufacturer’s guidelines, the DXA system were calibrated with a standard phantom 
each morning and the technicians were trained in accordance with standard operating 
procedures. Apart from this, errors might occur due to the behaviour of the participant prior to 
attending DXA. The DXA imaging can be influenced by hydration status (65). In the Tromsø 
Study, no preparations (such as fasting, emptying of bladder, or refraining from physical 
activity) were advised before the DXA scan. Hydration and intestinal content mainly affect 
the total body lean mass or lean mass in trunk and abdominal area, in that increased fluid- and 
food content in the stomach slightly increases the measures of lean mass. Further, high-
intensity training increase the blood-volume in the working muscle, leading to a slightly 
larger muscle mass in the imaging (65). Thus, non-fasting imaging affects mainly lean mass, 
and further total body mass and indexes such as body fat percentage (higher total lean mass 
leads to lower percent body fat). Future studies aiming at examining total body- or trunk lean 
mass should take these factors into consideration, even though hydration within normal range 
in fat-free tissues (67%-85%) will not affect the results (65). 
Secondly, measurement error during scanning might occur due to misplacement/wrongly 
positioning of the participant. This means that the participant is wrongfully placed in the 
DXA, causing scans to fail to include the whole body in the image, resulting in missing areas 
of the body. With missing areas of the body (e.g., left arm missing) the DXA application 
(CoreScan software, Encore 17.0) enables estimation of values for the missing part of the 
body by mirroring the other side of the body (e.g., the right arm). This is a useful solution 
when participants exceed the width of the DXA scanner. As such, the software reduces the 
potential errors arriving from this problem (65). The mirroring method has been enabled for 
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the image processing in the Tromsø Study, but during post-scan inspection of images the 
technicians discovered that some participants had exceeded the width of the DXA scanner on 
both sides with their arms. In those cases, mirroring is not possible to perform. This might 
affect the individual total-body measures, but abdominal area is fully imaged and therefore 
not influenced by this. Also, these errors accounted for only a small fraction of the 
participants.  
Thirdly, measurement errors can occur related to the precision of the DXA system. The DXA 
does not directly measure amounts of VAT, but rather estimates VAT from subtracting 
subcutaneous fat from total fat in the abdominal area (67). Although, VAT is not directly 
measured by DXA, it is highly correlated with VAT derived from the gold-standard methods 
for body composition analysis; CT and MRI (66, 67). However, Meredith-Jones et al. (92) 
showed that the precision of DXA‐derived VAT measurements varied depending on sex 
(lower precision in men) and body size (lower precision in those with obesity). Thus, the 
precision of DXA-derived VAT estimations decreases with increasing level of overweight. A 
potential explanation for the lower precision in men and participants with obesity might be 
that the imaging from DXA is influenced by the size of the participants, thus, more tissue and 
thickness means that there is more density, which might influence the attenuation of the X-
rays (92). According to Meredith-Jones et al., the differences, or changes, in VAT values 
should exceed 130 grams for it to be considered as actual changes, and not due to 
measurement error. In paper Ⅲ the changes in VAT from Tromsø 5 to Tromsø 6 was 48 g in 
women and 103 g in men, while the change from Tromsø 5 to Tromsø 7 was 200 g in women 
and 365 g in men. This is, however, mean changes of VAT. 
Finally, potential limitations can occur during post-scan management of the images. 
Measurement error from DXA-scan measures, might occur if a technician misplaces the ROIs 
in the post-handling of DXA images. Ten ROIs are usually applied to DXA-scan images, both 
during and after scanning, to assess body composition, separating the body into head, trunk, 
upper- and lower limbs, and into android and gynoid region (Figure 4) (65). Misplacement of 
these lines can interfere with the measures from the different regions and further produce 
wrong measures of body composition. Measures to reduce such limitations can be recruiting 
trained personnel and use thoroughly developed protocols. Potential limitations arriving from 
post-scan management errors are both difficult to discover and difficult to solve and requires 
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arduous quality control protocols that might be difficult to operate in large-scale data 
collection settings.  
5.1.5 Confounding and interaction 
In addition to bias resulting from design, selection and collection of information, other factors 
can affect and disturb the association between variables. Such factors are known as 
confounding factors, mediators, covariates, and moderators and can all influence the observed 
effect between exposure and outcome.  
A confounder is a variable that influences the association between an exposure and an 
outcome because the confounding variable is, in itself, associated with both the exposure and 
the outcome (80, 93). This can cause us to observe a false association because the association 
is driven by the confounder. A confounding variable is often recognized as a variable that 
alters the association between two variables with 15% (93). In paper Ⅰ and Ⅱ potential 
confounders are factors that alters the association between VAT, anthropometric measures 
and cardiometabolic risk factors. Such confounders might be dietary intake, physical activity, 
SES and hormones. We have not adjusted for these potentially confounding factors in the 
papers because the aim was merely to describe the association between VAT, anthropometrics 
and cardiometabolic risk, not explain or establish a causal association. However, studies 
aiming at describing a causal pathway between an exposure and an outcome are constantly 
being challenged by potential confounding factors (89, p. 33). Also, in paper Ⅲ we described 
the changes in body composition over time, without trying to explain the mechanisms behind 
the changes. However, we adjusted for birth year because it is well known that body 
composition changes with increasing age.  
Interaction is defined as “Differences in the effect measure for one factor at different levels of 
another factor” (78, p. 152). The term interaction is often described together with risk 
modification, because a factor that modify the effect of an exposure to an outcome is what 
leads to interaction between the exposure and outcome (80, p. 99). The concept of risk 
modification and interaction is different from confounding in that the modifying risk factor 
works interchangeably together with the exposure. Therefore, through a combined effect, 
increase or decrease the risk for the outcome. An example could be if the combined effect of 
higher VAT and e.g., hypertension increases the risk of cardiometabolic disease more than the 
expected effect of VAT and hypertension separately. Although it is accepted to use statistical 
42 
 
models to adjust for confounding effects (to remove the effect attributable to the confounding 
variable), merely adjusting for interaction is more complicated because removing the effect of 
a risk modifier might hide important results. In paper Ⅲ, we assumed that the effect of time 
on changes in body composition might be different in different birth cohorts, and thus tested 
for interaction. This assumption was based on previous studies showing different trends in 
different birth cohorts regarding trends in overweight and obesity (27-29, 31). We found a 
significant interaction between time and birth cohorts in women, i.e., there were differences 
between different birth cohorts in changes in body composition over time. In men, the 
estimated changes were different in different birth cohorts, but the interaction term between 
birth cohorts and time was not statistically significant. 
5.1.6 Longitudinal studies: effect of cohorts and time 
In paper Ⅲ, we presented both secular and longitudinal changes from Tromsø 5 (2001) to 
Tromsø 7 (2015-2016). Because both secular and longitudinal trends apply to trends over 
time, the definitions need to be clarified. Porta et al, (78, p. 257) defined secular trend as 
"Changes over a long period of time, generally years or decades". According to the 
dictionary of epidemiology, longitudinal studies are synonymous with cohort studies and 
Porta et al, (78, p. 50) define longitudinal trends as “The analytic epidemiological study in 
which subsets of a defined population can be identified who are, have been, or in the future 
may be exposed or not exposed or exposed in different degrees, to a factor or factors 
hypothesized to influence the occurrence of a given disease or other outcome.”. Although 
both definitions regard trends across time, secular trends are time trends without requiring the 
same participants, while longitudinal trends are repeated measures of the same individuals 
over time. In analyses of trend, the findings can be influenced by three factors: the time of the 
study, the age of the participants and the birth cohort of the participants. The aim of paper Ⅲ 
was to examine if there was an effect of time on changes in body composition, in addition we 
knew that the effect across time might be influenced by both age and birth cohorts.  
Longitudinal studies enable for examining potential differences in trends in sub-groups of the 
study population such as sex and cohorts. Thus, we had the opportunity to investigate if the 
trends over time differed in different sub-groups. Birth cohorts are defined as "participants 
born at a particular time" (89, p. 56). In paper Ⅲ we presented trends in 10-year age groups 
(in 2001) to represent birth cohorts. The different age groups and their corresponding birth 
cohorts are clarified in Figure 7. In paper Ⅲ we addressed these differences as age groups (in 
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2001) but have used the term birth cohorts in this thesis to avoid confusing the differences 
with age-effects.  
The estimated overall time-trend might mask important findings, such as the findings from 
paper Ⅲ where the increase in body fat and VAT mass were higher in the younger birth 
cohorts compared with older birth cohorts. This is important to explore when investigating 
changes across time because a stable time trend in mean level of a factor can be masked by 
positive time trends in one group and negative time trends in another.  
 
Figure 7: Age-groups in 2001 and their corresponding birth cohorts. 
 
Time trend analysis was only performed in paper Ⅲ, but it would be valuable to also 
investigate the association between VAT and cardiometabolic risk across time. Further, trend 
analyses would be important to establish whether VAT is a stronger causal factor for 
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cardiometabolic risk over time, compared to the anthropometric measures. However, the 
number of participants with valid VAT measures in Tromsø 5 and Tromsø 6 who had MetS in 
Tromsø 7 were limited, 26 women and 22 men in Tromsø 5 and 128 women and 86 men in 
Tromsø 6. Thus, showing a causal association between VAT mass and MetS (at a later time 
period) would have been challenging.  
5.1.7 External validity 
Porta et al, (78, p. 288) defines external validity as “the degree to which results of a study 
may apply, be generalized, or be transported to populations or groups that did not participate 
in the study”, i.e., that the study results are transferable and of interest to populations beyond 
those included in the study. In paper Ⅰ, we created reference- and threshold values for 
comparison with other populations and time periods. However, there are several subjects for 
caution that needs to be addressed. Firstly, the reference- and threshold values are only 
comparable to other studies or settings using the Lunar Prodigy DXA. As stated above, the 
extrapolated data are specific for the manufacturer’s scanner and software. Secondly, the 
reference- and threshold values are only applicable to similar populations, with similar ages 
and living conditions. Further, because the thresholds for VAT are created based on the 
sensitivity and specificity for MetS, all the potential causes for misclassification mentioned 
above might alter the classification, and further affect the thresholds presented. Therefore, 
caution is warranted when applying these thresholds outside this study sample. Further 
studies, using the MetS and the same statistical approach, is needed for comparison with the 
thresholds created in paper Ⅰ. However, acknowledging the potential limitations arriving from 
the concepts discussed from section 5.1.2 through 5.1.6, overall, the findings in both paper Ⅱ 
and Ⅲ are concluded to be generalizable for the general adult population, given that the living 
conditions are similar, and that body composition is measured with the same DXA-system as 
in the Tromsø Study sample. 
5.1.8 Statistical considerations 
VAT was not normally distributed but rather positively skewed. However, VAT was 
transformed for one analytical purpose only, to enable for comparison between strength of 
association of different units of VAT (grams, index, and %) through regression analysis in 
paper Ⅰ. We chose to not transform VAT for other purposes based on the following 
reflections. Firstly, the sample size included in the papers are quite large. The central limit 
theorem states that samples consisting of more than 30 participants are reasonable large, and 
45 
 
that in such samples the mean is often normal, even if skewness occurs (91, p. 125). This 
rationale is strengthened as sample size increases. The mean was similar to the median (a 
differences of 105 g in women and 83 g in men in Tromsø 7). Secondly, we mainly aimed to 
describe associations rather than examining the effect of VAT on MetS. The statistical 
methods applied did not rely on normal distribution. ROC curves with AUCs are merely 
graphical descriptive statistics and nonparametric ROC curves in combination with 
postestimation ROC curves from logistic regression was used. None of which includes an 
assumption of normality. In paper Ⅲ we used GEE analysis, which is well suited for handling 
non-normally distributed variables (94).  
In all three studies we started with, what Bhopal called “the first key analysis in all 
epidemiological studies” (80, p. 96), namely descriptive analysis of our study population. 
Paper Ⅰ and Ⅱ will be discussed together because the same study sample was included and 
because similar methods were used.  
Paper Ⅰ & Ⅱ 
We decided that the most important aspect of considering body composition is to relate it to 
risk of disease. We used ROC analysis to examine the different units of VAT (grams, index, 
and %) (paper Ⅰ) and VAT mass (grams) plus the different anthropometric measures’ (paper 
Ⅱ) ability to predict MetS. ROC analysis is usually used for determining the predictive 
abilities of a medical test to confirm positive disease that is present, or to compare the 
diagnostic decision from two different factors (i.e., tests or doctors) (95, 96). It is a useful and 
increasingly used tool in epidemiological research to compare predictive effects of a variable 
against a measure considered better/more correct (VAT), and further to create threshold 
values. Youden’s index is a commonly used post-estimation tool from ROC curves to create 
threshold values or cutoffs based on the sensitivity and specificity of a test (95). We used 
MetS to classify the threshold of VAT that had the best ability to discriminate between 
participants with and without MetS. It should be noted that this does not mean that slightly 
lower levels of VAT are not of concern, but rather that values above those reported in paper Ⅰ 
are highly associated with having MetS. It should also be emphasized that the thresholds 
presented are depending on the prevalence of MetS in our population and is as such only 
applicable to populations similar to ours in regard to MetS. Finally, our definition of MetS is 
based on the commonly used NCEP ATP Ⅲ criteria, but some modifications are made, such 




We wanted to examine whether differences in sample characteristics between participants 
attending only one survey compared to those re-attending several surveys potentially could 
affect the observed trends in body composition. To present sample characteristics we 
compared mean levels of HDL cholesterol, triglycerides, waist circumference and proportion 
of smoking, hypertension, sedate physical activity level, and higher education in those with 
one compared to more than one Tromsø Study attendance. We first compared the 
characteristics between the sample in Tromsø 5 that attended only Tromsø 5 with those also 
attending Tromsø 6 or Tromsø 7. Further, we compared the sample in Tromsø 7 that attended 
only Tromsø 7 with those also attending Tromsø 5 or Tromsø 6. All participants attending 
DXA measurements in Tromsø 6 also attended DXA scans in either Tromsø 5 or Tromsø 7. 
The differences between the samples attending only one survey and those attending more than 
one of the included surveys were minor with respect to clinical significance. To examine 
secular trends, we presented mean values of VAT and body fat in 10-year age groups in the 
three surveys, compared kernel density plots and used GEE analysis to present overall trends 
in women and men. Because the GEE analysis estimates values for those that are missing in 
each survey, it could be considered an analysis of longitudinal trend (because we present it as 
trends in the same participants). Because we, in this specific analysis, only presented overall 
trends and did not examine sub-groups in the population, besides separating women and men, 
we present it as secular trends.  
The number of participants attending DXA scans in the three surveys differed. GEE analysis 
is well suited for longitudinal analyses because it accounts for correlations within individuals 
with repeated measures, and also because it estimates changes and trends for the missing 
values at each time point (94). A total of 940 participants attended DXA scans at two or more 
of the surveys, and 382 participants attended DXA scans in all three surveys (Tromsø 5, 
Tromsø 6, and Tromsø 7). The highest number of participants attended DXA scans in Tromsø 
7 and among these 3675 participants, 87% did not attend previous DXA scans. Thus, GEE 
estimates values for these participants in Tromsø 5 and Tromsø 6. To examine whether these 
estimated trends for missing variables were different from those with complete follow-up, we 
performed two rounds of sensitivity analysis: one including participants attending 2 surveys 
or more, and one including only those attending all three surveys. The results from these 
sensitivity analyses were similar to that observed in the main analysis (including all 
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participants attending one of the surveys). GEE analysis assumes that the missing values are 
missing at random. There is no reason to believe that the participants missing from survey to 
survey is due to systematic differences. Thus, together with the highly similar results from the 
sensitivity analysis presented above, we do not believe that wrongfully estimated results due 
to missing not at random has influenced our results. 
Finally, the most important consideration when choosing a statistical method is that it should 
be suitable for answering the aims. We consider our statistical approaches to be suitable for 
the aims presented in the three papers.  
 Discussion of main results 
The results have been discussed in detail in the three included papers. In this section I aim to 
review the findings with a wider perspective and reflect on how these results can have 
implications on further research, clinical practice and future interventions aiming at halting 
the obesity epidemic. 
Overweight and obesity are increasing in all parts of the world (11). BMI is the most 
frequently used measure to quantify overweight and obesity. The increase in obesity is 
paradoxical to the improvement in cardiometabolic risk. We originally questioned whether the 
observed changes in BMI actually reflect an unhealthy increase in total body fat, or if the 
population is becoming generally larger, not merely fatter. Because BMI reflects weight 
divided by height squared, it does not address whether this increase in weight consists of fat 
mass or muscle mass. Thus, potentially increasing trends in muscle mass would be masked as 
overweight by using BMI alone. In the Tromsø Study, the adult population have over time 
increased their grip strength and their levels of leisure time physical activity (97, 98). Both 
these trends might indicate a better health status in the adult population and a higher muscle 
mass. VAT is identified as the most harmful fat depot in the body, closely associated to 
cardiometabolic disease. It was therefore of importance to use DXA to investigate whether the 
observed paradox could be explained by a low correlation between VAT and other 




5.2.1 VAT: reference values and thresholds 
Although VAT for a long time has been recognized as a metabolically active component of 
body fat tissue (35, 51), the EnCore version 17.0 software enabling VAT estimations from 
DXA through the Corescan application was first evaluated in 2010-2011 (67). Previous 
studies creating reference values for DXA-derived VAT is rather limited, probably because 
the DXA system is quite expensive and requires extensive mobilizations of site, technicians, 
and protocols. Current reference values for VAT is based on younger populations (99, 100), 
based on the more recently released iDXA scanner (101, 102) or based on the DXA scanner 
from Hologic Inc. (Bedford, MA, USA) (103). Ofenheimer et al. (104) used the Austrian 
LEAD cohort to present reference values for European populations, however, they did not 
propose thresholds or compare VAT with cardiometabolic risk. Corresponding to Ofenheimer 
et al. (104) we observed that men had higher VAT mass than women. While they observed a 
continuous increase in VAT mass with increasing age, we observed a decrease in VAT mass 
after the age of 70. The mean VAT mass in different age groups presented by Ofenheimer et 
al. (104) were similar to that observed in paper Ⅰ in women, while men in paper Ⅰ had 
consistently slightly lower mean VAT mass in the different age groups than the Austrian men 
(104). Ofenheimer et al. emphasized the need for similar studies in different population to 
examine potential geographical differences (104). Recently, reference values and threshold 
values for VAT were presented from a New Zealand population by Meredith-Jones et al. 
(105). In this study, the proposed cutoff values were markedly lower than our findings; 800 
grams versus 1100 grams in women, and 1200 grams versus 1860 grams in men. These large 
differences might be explained by the age differences in the samples. Meredith-Jones et al. 
(105) included participants 18-66 years, but presented reference values separately for women 
and men <40 years and 40 years and older. Thus, in our paper Ⅰ, we compared our results with 
their presented reference values for women and men 40 years and older. Still, the mean age of 
our sample is older than that included by Meredith-Jones et al. (105) because the oldest 
participants in our sample were 84 years old while the oldest in their sample were 66 years. 
The mean age of participants 40 years and older included by Meredith-Jones et al. were about 
45 years in both women and men, while the mean age in our sample were about 66 years in 
both women and men. Because the amount of VAT increases with increasing age, it is 
plausible that this age-differences explain the discrepancy between our findings. Other 
examples of potential explanatory factors might be study sample differences in diet and 
physical activity level, but possibly also because of different methods and criteria used when 
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creating cutoffs. Meredith-Jones et al. (105) used single metabolic components, and later 
combined these results, while we used the MetS definition. Further, they used a method 
presented as the Liu method, which is described as an alternative to the Youden’s index 
method, which was used in our paper Ⅰ. However, the differences in thresholds are still 
notably large (300 grams in women and 860 grams in men) (105).  
Comparisons across studies provides new valuable insights about population health, enabling 
us to compare population differences and predict future risk for disease. Further, and 
importantly, we can motivate for public intervention targets. However, comparison would be 
more feasible if different studies used similar methods and outcomes when creating threshold 
values.  
5.2.2 Overweight measures and cardiometabolic risk 
Overweight, and particularly obesity, increases the risk of cardiometabolic disease, and 
previous results corresponds to ours regarding the high correlation between VAT and 
anthropometric measures (100, 106, 107), and the strong association between VAT and 
cardiometabolic risk (35, 100, 105, 106, 108). There was a statistically stronger association 
between VAT and MetS, but the predictive effects of VAT compared to anthropometric 
measures, represented by the AUC, was highly similar. Thus, anthropometric measures are 
concluded to be satisfactory substitutes for DXA-derived VAT in population surveys, and 
waist circumference more so than BMI, WHR and WHtR. This might be a controversial 
conclusion because imaging methods are more accurate than anthropometric measures.  
The conclusion should be interpreted with caution and with the understanding that it is not 
necessarily generalizable to all settings or individuals. Firstly, it is possible that DXA-derived 
VAT is more strongly associated with disease occurrence over time. That is reasonable to 
assume since VAT is more strongly associated with reduced insulin-sensitivity, pro-
inflammatory responses, and free fatty acids, than obesity in general (55). Further, individual 
differences in body compositions might be masked by anthropometric measures such as BMI. 
BMI has limited potential to capture whether excess weight consist of muscle mass. However, 
it is unlikely that BMI levels above e.g., 30 kg/m2 is due to excess muscle mass alone. This 
would only occur in individuals with an extreme muscle mass, such as athletes in particular 
sports including body builders, and is not considered a fallacy of BMI in existing populations. 
Further, two individuals with similar BMI (e.g., obesity) might have different risk for 
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cardiometabolic disease depending on the amount of VAT (55). Also, there are several 
challenges to measuring and defining overweight and obesity in the elderly population. Not 
only have the more commonly used anthropometric measures shown to be inadequate in 
detecting obesity because of the biological changes in body composition with increasing age 
(61), but potentially also because of the suggested u-shaped association between BMI (and 
waist circumference) and disease in the older population as described in the introduction (45). 
Thus, if low weight/underweight serve as a risk factor in the elderly population, having 
overweight might seem protective compared to having underweight (62). However, a large 
review from 2016 (46) showed that there was a u-shaped association between BMI and 
mortality, but that this association most likely were influenced by potential confounding of 
factors such as smoking and presence of disease. The association between BMI and mortality 
in never-smokers was J-shaped and the BMI on 23-24 presented the lowest mortality (46).  
Thus, although the findings from this thesis can be important for clinicians, the need for 
discretion and use of “common sense” is important because of the limitations of the 
anthropometric measures. In epidemiological studies it is not possible to draw inferences to 
individuals, mainly because we do not study individuals but populations. Epidemiology is 
“the study of occurrence and distribution of health-related events, states, and processes in 
specified populations.” (78, p. 95). Therefore, these considerations about potential individual 
differences are presented as an area in need for caution when deciding which measures that 
are most appropriate. 
Finally, we examined the associations between VAT, anthropometric measures and 
cardiometabolic risk factors, focusing on the MetS components hypertension, high 
triglycerides, low HDL cholesterol and finally diabetes prevalence. Thus, our conclusions and 
considerations only regard association to cardiometabolic risk and MetS, and we cannot 
conclude on either of these different measures in their association to other morbidities like 
e.g., cancer, or overall mortality.  
5.2.3 Changes in body composition 
In paper Ⅲ, both VAT and body fat increased between 2001 and 2015-2016. The increase 
was higher during the two latest surveys (2007-2008 and 2015-2016) and in the youngest 
birth cohort compared to the older birth cohorts (with significant differences in women only).  
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We did not find any previous studies examining the secular trend in DXA-derived body 
composition. Therefore, the results were compared to other studies examining longitudinal 
trends in body composition (61, 109-112). The results from previous studies corresponded to 
the findings from paper Ⅲ, but the previous studies had a small number of participants (N: 
78-161) (61, 110, 112), and included older adults (60+ years), aiming at investigating change 
in body composition and sarcopenia. Further, all studies had short follow-up (2-5 years) (61, 
109-112). It should be noted that one of these studies (109) used the Hologic DXA system, 
making direct comparison of results challenging. Nor did we find any studies presenting 
trends in DXA-derived VAT and paper Ⅲ thus contributes with novel findings to the field.  
Paper Ⅱ showed high correlation and strong association between VAT and waist 
circumference. Previous findings from the Tromsø Study showed that trends in waist 
circumference corresponded to the trends in VAT observed in our paper. This related both to 
the increase over time, but also to the cohort effect where the younger birth cohorts have a 
higher increase in prevalence of obesity compared to the older birth cohorts (29, 31, 113). 
While we observed a more rapid change between the two latest surveys in our study, Jacobsen 
et al. (28) found a higher increase in BMI between the earlier time periods 1994-1995 to 
2001-2002 than between 2001-2002 to 2007-2008. However, Jacobsen et al. followed the 
participants between Tromsø 4 (1994-1995) to Tromsø 6 (2007-2008), thus not fully 
overlapping the three surveys included in our paper (Tromsø 5 to Tromsø 7). Løvsletten et al. 
(31) showed that both body weight and waist circumference increased between Tromsø 6 and 
Tromsø 7, supporting the increasing trends observed in paper Ⅲ. The more rapid increase in 
obesity among the younger generations observed in paper Ⅲ is of special concern because 
overweight usually follows the person into adulthood and older age (114, 115). Thus, higher 
increase in younger generations might lead to a further increase in the prevalence of 
overweight and obesity, which again might hamper the positive development of 
cardiometabolic disease observed in developed countries.  
Contrasting to the results from the Tromsø Study, the HUNT study showed in their public 
health report from 2019, that the increasing trend in overweight had flattened between 2006-
2008 to 2017-2019 (116). The results from HUNT were presented for the participants overall 




5.2.4 General considerations 
This thesis’s conclusion reflects that DXA-derived VAT is not necessarily essential to 
establish associations with cardiometabolic risk at a population level, and that the trends 
observed in VAT and body fat are similar to that observed using BMI, which is more 
accessible.  
DXA is important when investigating changes in body composition across time, age, and 
cohorts. Firstly, DXA is valuable in intervention studies when measuring the effect of, for 
example, physical activity and dietary interventions over time. During such studies the 
participant’s body composition might change by increasing muscle mass and reducing fat 
mass, while their weight might remain stable. In that case, conventional anthropometric 
measures, such as BMI, might not capture the positive changes in body composition and 
further the positive impact of the intervention. Secondly, the biological changes in body 
composition with increasing age is characterized by a decrease in muscle mass and increase in 
fat mass, and especially abdominal fat mass (44, 63). The loss of muscle mass and reduced 
function in the elderly population is defined as sarcopenia (49). Studies have shown that these 
transitions in body composition might not be detected by standard measures, because 
simultaneously with a reduction in muscle mass, fat mass increases, leading to a relatively 
stable body weight (61, 112). These changes occur more rapidly in some elderly leading to 
premature aging. To capture changes in body composition, imaging methods are undoubtable 
of high importance.  
The results and conclusions from this thesis are based on a population approach and mean 
values. This means that the results are considered generalizable to the general population but 
may not be generalizable to those who differ from the general or average. Thus, for the 
average population, anthropometric measures and especially waist circumference is a 
satisfactory measure for determining risk for disease. However, for an individual that differ 
significantly from the average, e.g., regarding muscle mass or body size, anthropometric 
measures might prove less useful. Epidemiological studies aim at studying populations, 
therefore, applying the results to individuals should be done with caution, if done at all. 
Currently, individuals with particularly high muscle mass make up a small part of the general 
population and is not believed to have altered the conclusions from this thesis. With parts of 
the population being more physical active and stronger than previously, using anthropometric 
measures such as BMI might impose a challenge in the future.  
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Because DXA is a rather resource demanding tool, other body composition measuring tools 
such as bio-electrical impedance (bioimpedance) analysis is more frequently used in hospitals 
and in gyms. Bioimpedance is ranked as the third level of accuracy according to Lohman et 
al., (56), together with circumference measures (such as waist circumference). In comparison 
with MRI, bioimpedance is a good measure for abdominal fat overall, but not as good for 
estimating VAT (117). It is not clear if bioimpedance is better than waist circumference at 
estimating VAT, and also, the possibility of error is large with higher level of VAT (58). 
Further, the accuracy of bioimpedance is highly depending on the participants hydration 
status and correct placement of electrodes (56, p. 78). Overall, DXA scans are considered 
superior to bioimpedance according to level of accuracy in measuring body composition, and 
especially VAT. However, in some cases DXA is not possible to perform. The DXA-scanner 
cannot scan participants with a body weight over 200 kg (65). In such cases bioimpedance can 
be considered a potential substitute. 
Due to the cross-sectional design of paper Ⅰ and paper Ⅱ, it cannot be concluded whether there 
is a causal relationship between VAT and MetS, nor can it be concluded that the 
anthropometric measures are equally good as VAT in future prediction of MetS, or other 
cardiometabolic conditions. Thus, the study design is a potential limitation that needs to be 








In this thesis we hypothesized that DXA-derived VAT would be a more accurate measure of 
obesity and that it would have stronger association to cardiometabolic risk. Further, we 
questioned whether the observed trends in obesity measured by BMI would reflect a similar 
trend in body fat and VAT.  
The presented reference values and threshold values for DXA-derived VAT are of potential 
value to future studies or clinics using similar techniques and including similar populations as 
used here. In comparison with the commonly used and easily accessible anthropometric 
measures, BMI, waist circumference, WHR and WHtR, VAT was statistically, but not 
clinically, significantly stronger associated with MetS and the single MetS components 
(hypertension, diabetes, high triglycerides and low HDL cholesterol). Both VAT and body fat 
increased from 2001-2016 with a larger increase between 2007-2008 and 2015-2016, and in 
the youngest birth cohorts (40-49 years). The difference in estimated increase of VAT and 
body fat across time between different age-groups were statistically significant in women 
only.  
In conclusion, the results imply that on a general basis and in large population studies, DXA-
derived VAT seems to mirror the observations of anthropometric measures, and the 
anthropometric measures can therefore be regarded as satisfactory substitutes in studies and 
sites where DXA measures are challenging. Caution should be used when investigating 
longitudinal trends in intervention studies aiming on weight reduction or in the older part of 
the population. Further, the observed trend in body composition mirrored that observed by 
BMI, thus reflecting an actual increase in body fat across time.  
The findings in this thesis suggests that the difference between DXA and anthropometric 
measures were minor, both according to their association to MetS and according to time 
trends. It is, however, important to highlight that the participants with obesity, regardless of 
measurement method, are at higher risk for cardiometabolic disease, and potentially also at 
higher risk for other diseases not addressed in this thesis. Our hypothesis that the paradox 
between improvements in cardiometabolic risk and a continuous increase in overweight and 
obesity could be explained by the population getting larger, not merely fatter, is not supported 






7 Implications and future perspectives 
There are several implications arriving from this thesis. The reference values and thresholds 
created for VAT is potentially valuable for future studies to enable for comparison, or to 
support decision-making in clinical settings. We have shown that VAT values over a given 
threshold implies a three to four times increased risk for MetS. It would be useful for future 
purposes to have generally accepted threshold values for VAT– across populations and 
diseases. Thus, more studies are needed to establish reference- and threshold values, 
preferably with similar methods and in prediction of cardiometabolic diseases. Further, 
showing that anthropometric measures are satisfactory substitutes for more advanced methods 
are of high value for both population studies and clinics that does not find it feasible to 
include advanced measures of body composition. However, caution should be made as the 
measures included should match the aim of the measurements. The secular and longitudinal 
trends in body fat and VAT mass confirms what has previously been observed in the obesity 
epidemic where overweight and obesity consistently increase, with the largest increase in the 
younger population. The higher increase of VAT and body fat in the younger generations is of 
considerable concern and should be a strong motivator for large public health measures 
aiming at halting the current and future increase in overweight and obesity.  
From a cost-effectiveness perspective, given the high economic consequences of obesity, 
reducing both individual and societal costs arriving from obesity, is most likely highly cost-
effective. The continuing challenge in the battle against obesity is not that we do not have the 
means, but that reducing weight and staying normal weight requires massive efforts and 
motivation from individuals. Overweight and obesity are caused by a complex interplay 
between genetic factors and lifestyle. However, although people with genetic predisposition 
for obesity has increased most in BMI, people not genetically predisposed have also increased 
in BMI, indicating that environmental factors are strong drivers behind the continuous 
increase (118). Therefore, preventive targets should be interdisciplinary, placing less focus on 
individuals, and more heavily emphasized on public and organizational measures. Such 
measures could include reducing the costs and increasing the availability of healthy foods, 
increasing the costs and reducing the availability of unhealthy foods, aiming at discovering 
and facilitate for early intervention of overweight and obesity, and enabling for physical 
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activity for all parts of the population. The solution to the obesity epidemic is complex, 
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Background. Reference values for visceral adipose tissue (VAT) are needed and it has been advocated that body composition
measures depend on both the technique andmethods applied, as well as the population of interest. We aimed to develop reference
values for VAT in absolute grams (VATg), percent (VAT%), and as a kilogram-per-meters-squared index (VATindex) for women
and men, and investigate potential differences between these measures and their associations with cardiometabolic risk factors
(including metabolic syndrome (MetS)).Methods. In the seventh survey of the population-based Tromsø Study, 3675 participants
(aged 40–84, 59% women) attended whole-body DXA scans (Lunar Prodigy GE) from where VAT was derived. We used
descriptive analysis, correlations, receiver operating characteristics (ROC), and logistic regression to propose reference values for
VATand investigated VAT’s association with cardiometabolic risk factors, MetS and single MetS components. Further, Youden’s
index was used to suggest threshold values for VAT. Results. VATg and VATindex increased until age 70 and then decreased, while
VAT% increased with age across all age groups. VAT (all measurement units) was moderate to highly correlated and significantly
associated with all cardiometabolic risk factors, except for total cholesterol. Associations between MetS, single MetS components,
and VATg and VATindex were similar, and VAT% did not contribute any further to this association. Conclusion. (ese VAT
reference values and thresholds, developed in a sample of adults of Norwegian origin, could be applied to other studies with
similar populations using the same DXA device and protocols. (e associations between VAT and cardiometabolic risk factors
were similar across different measurement units of VAT.
1. Introduction
(e definition of overweight and obesity is “abnormal or
excessive fat accumulation that may impair health” [1]. (e
most frequently used definitions of overweight and obesity
are based on anthropometric measures such as body mass
index (BMI) and waist circumference, which do not dis-
tinguish between fat mass and fat free mass, but rather
represent overall body size. On the contrary, available body
composition measures directly address the definition of
overweight and obesity. (ere are several tools to determine
body composition. Dual energy X-ray absorptiometry
(DXA) determines body composition from scanning the
body with X-ray beams that pass through the body and
establish amount of fat mass, bone mass, and soft tissue lean
mass based on composition of the tissues [2–4]. Visceral
adipose tissue (VAT) located intra-abdominally (behind the
abdominal muscles and around organs) is more metaboli-
cally active than subcutaneous adipose tissue and has been
associated with insulin resistance, the metabolic syndrome
(MetS), cardiovascular disease, and several types of cancer
[5]. DXA provides area-specific body composition, and VAT
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is estimated from fat mass located in the abdominal area
when subcutaneous fat has been removed [3]. DXA-derived
VAT has been validated against both MRI and CT [3, 6].
(ere are no generally accepted reference values for VAT.
Previous studies have presented normative data, and there is a
need for age-, sex-, and ethnicity-specific reference values
[7–9]. In addition, different types of DXA systems and models
as well as the type of unit used challenge VAT comparisons
across studies. (e most commonly parameters reported from
the DXA systems are VAT mass expressed in grams (VATg)
and VAT volume expressed in cubic centimeters (VATcm3).
(ere is a strong positive correlation between height and
weight, and likely also between height and VAT, and between
body fat and VAT. To increase comparability between indi-
viduals, it is of interest to adjust for potential confounding
effects of height and central adiposity, warranting relative VAT
values like VATindex (VAT/height2) and percent visceral fat in
the abdominal area (VAT%). Previous studies developing VAT
reference values have highlighted the importance of technique
and population-specific reference values [7].Most other studies
have used iDXA models [8, 10] or only included young adults
[9, 11]. In addition, few studies have investigated the associ-
ation between VAT and cardiometabolic risk factors
[7, 9, 11, 12].
We aimed to develop reference values for DXA-derived
VAT expressed in absolute and relative terms in an adult
population, predominantly of European origin from the
Tromsø Study, Norway. Additionally, we have investigated
the associations of distinct VAT parameters with car-
diometabolic risk factors, MetS and single MetS compo-
nents. Further, we present suggested threshold values of
VAT based on ability to predict MetS.
2. Materials and Methods
2.1. Study Population. (e Tromsø Study is an ongoing
population-based study [13] consisting of seven surveys
(Tromsø 1–7) conducted from 1974 to 2016, inviting large
representative samples of the population in the Tromsø
municipality in Northern Norway. We included participants
from Tromsø 7 (2015–2016) where all inhabitants aged 40
years and older (N= 32591) were invited to a basic exami-
nation including questionnaires, clinical measurements, and
biological sampling (Figure 1). A subsample (N= 13028) was
premarked for invitation to extended examinations ap-
proximately two weeks later. (is subsample consisted of a
randomized sample (N= 9925) as well as previous partici-
pants attending DXA, echocardiogram, and eye examina-
tions in Tromsø 6 (2007–2008) (N= 3103). A total of 21083
women and men aged 40–99 years attended the basic ex-
amination (65%), and 8346 attended the extended exami-
nations (of the premarked sample; 64% of the originally
premarked and 90% of those attending the basic exami-
nation). Of these, 3683 participated in DXA scans from
whom 3675 had VAT measures available (Figure 1).
(is project was approved by the Regional Committee
for Medical Research Ethics (REC North ref. 2017/1967),
and all participants gave written informed consent.
2.2. Study Measures. All measurements were performed by
trained staff using standard protocols.
2.2.1. Cardiometabolic Risk Factors. We included informa-
tion on diabetes and use of medications from self-administered
questionnaires. Nonfasting blood samples were analyzed for
total cholesterol (mmol/L), high-density lipoprotein (HDL)
cholesterol (mmol/L), triglycerides (mmol/L), and glycated
hemoglobin (HbA1c) (%), at the Department of Laboratory
Medicine at the University Hospital of North Norway (ISO
certification NS-EN ISO 15189 : 2012). Blood pressure was
measured three times with two-minute intervals with a
Dinamap ProCare 300 monitor (GE Healthcare, Norway) and
the mean of the two last readings was used in the analysis. We
usedMetS components based on the NCEP ATP III diagnostic
criteria for the MetS (2005 revision): hypertension (mean
systolic blood pressure >130mmHg and/or mean diastolic
blood pressure >85mmHg and/or use of antihypertensives),
high nonfasting blood lipids (triglycerides ≥1.7mmol/L and/or
use of lipid-lowering drugs), low HDL cholesterol (HDL
cholesterol <1.3 (women) or <1.0 (men) mmol/L and/or use of
lipid-lowering drugs), and diabetes (self-reported diabetes and/
or HbA1c≥ 6.5% and/or use of insulin and/or other diabetes
medication) [14]. As investigation of VAT was our main ob-
jective, we excluded elevated waist circumference as a criterion.
Invited to tromsø7 (2015-2016):
32 591
Excluded









did not attend DXA:
4663
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Figure 1: Inclusion of participants.
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MetS was defined as presence of three or more of the MetS
components presented above, as defined by NCEP ATP III (n:
493 (24%) women and 406 (28%) men).
2.2.2. Adiposity Measures. Weight and height were mea-
sured with light clothing and no shoes to the nearest 0.1
kilograms (kg) and 0.1 centimeters (cm) using the Jenix DS-
102 height and weight scale (Dong Sahn Jenix, Seoul, Korea).
Waist and hip circumference were measured to the nearest
0.1 cm with a Seca measurement tape at the level of the
umbilicus and the greater trochanters, respectively. BMI
(weight in kg divided by height in meters (m) squared) was
defined as normal (<25 kg/m2), overweight (25–29.9 kg/m2),
or obese (≥30 kg/m2). (e 31 women and 2 men with un-
derweight (BMI <18.5 kg/m2) were merged with the normal
weight category.
Whole-body DXA scans (Lunar GE Prodigy Advance, GE
Medical Systems) were performed according to the manu-
facturer guidelines, by trained technicians who inspected the
postscan images and made relevant quality corrections to the
regions of interest according to a standardized protocol. (e
DXA device was calibrated each morning with a phantom
ahead of measurements. Total body fat in grams and per-
centage and android fat mass in grams were measured directly
by DXA, and VATg and VATcm3 were subsequently com-
puted by the validated CoreScan software (EnCore version
17.0). VAT%was calculated as 100 ∗ VATg divided by android
fat mass (g), and subcutaneous fat mass was calculated as
android fat mass (g)−VATg. VATindex was calculated as
VAT kg/height (m)2.
2.3. Statistical Analysis. We used STATA 16 (STATA Corp
LP, College Station, Texas, USA) to perform all analyses. P
values were considered significant at a 0.05 level. VATg and
VATcm3 were highly similar in all analyses; thus, we present
only VATg to represent absolute value.
A total of 3675 participants (58.6% women) aged 40–84
years were included (Figure 1). We used descriptive statistics
to present characteristics of the study population (Table 1).
VAT measures with value of 0 (n= 10) were transformed
into lowest value (2 g). To compare participants attending
only basic examination with those additionally attending
extended examinations, we used Student's t-test (Supple-
mentary Table 1). We present sex specific means with
standard deviations (SDs), confidence intervals (CIs), and
percentiles (5th, 25th, 50th, 75th, and 95th) by 10-year age
groups for VATg, VATindex, and VAT% (Supplementary
Tables 2–4). To explore the association with VAT (g, index
and %) and cardiometabolic risk factors, we used age-ad-
justed partial Pearson correlation coefficients (Table 2). To
investigate the ability of VAT to predict MetS and single
MetS components (hypertension, diabetes, elevated tri-
glycerides, and lowHDL cholesterol), we performed receiver
operating characteristic (ROC) analyses with presentation of
age-adjusted area-under-the-curves (AUCs) (Table 3). To
further explore if any of the included units of VAT were
better than the other in predicting MetS or single MetS
components, we used both log likelihood test
(Supplementary Table 5) and c-statistics (Supplementary
Table 6). As VATg and VATindex were not normally dis-
tributed, they were transformed to square root, and z-scores
were subsequently created for inclusion to the logistic re-
gression models to study their associations with MetS or
single MetS components. In addition, we stratified the an-
alyses of the association between z-scores of VAT (all units)
and the presence of MetS or single MetS components in
categories of BMI (normal weight, overweight, and obese)
(Table 4). Lastly, we used ROC analysis of VAT in prediction
of MetS to derive sensitivity and specificity. Further, we
applied Youden’s index ((sensitivity + specificity)-1) [15] to
present suggested threshold values of VAT based on esti-
mated optimal cutoffs (all units) (Table 5) [16]. We used
logistic regression analysis to present the odds for MetS for
each of the presented threshold values of VAT (all units)
(Table 5).
Normality distribution of VAT (g, index and %) was
checked by visual inspection (Figure 2). VATg and VAT-
index were positively skewed. We explored how mean VAT
(g, index and %) and mean subcutaneous fat change across
age (Figure 3). To investigate percentiles (5th, 25th, 50th, 75th,
and 95th) of VAT (g, index and %) over 10-year age groups,
we performed line plots with separate lines for each per-
centile (Figure 4).
3. Results
(e mean age was 66.2 (8.92) and 65.9 (9.13) years, and
mean BMI was 26.8 (4.70) and 27.6 (3.72) kg/m2, in women
and men, respectively (Table 1). (e mean age of the women
and men attending only basic examinations was 55.1 (10.9)
and 55.9 (11.1). Compared to the participants attending the
basic examinations only (Supplementary Table 2), those
attending the DXA scanning had lower body weight and
height. (ere were no differences in BMI or waist cir-
cumference in women and a small difference in BMI in men
(27.9 and 27.6 kg/m2, P � 0.007).
3.1. VAT Reference Values. VAT (all measurement units)
was higher in men than in women and increased up to age 70
in both genders (Supplementary Tables 2–4 and Figure 3).
(e exception was VAT%, which continued to increase after
attained age of 70–79 in women, while the curve flattened at
age 70–79 in men (Figure 3). Subcutaneous fat, however,
decreased rapidly after age group 70–79 in women and
decreased linearly with age in men, which explains why VAT
% continued to increase after age group 70–79, while both
VATg and VATindex decreased in women.(e investigation
of VAT (all measurement units) in percentiles (5th, 25th, 50th,
75th, and 95th) across age groups showed highly similar
patterns for VATg and VATindex in both women and men
(Figure 4). In women, the pattern of the 5th percentile (VATg
and VATindex) was quite consistent across age, while the
25th, 50th, and 75th percentile increased until age group
70–79 before it then slightly decreased (Figure 4). (e
pattern for the 95th percentile (VATg and VATindex) was
markedly higher and differed from the other percentiles. In
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addition, the 95th percentile (VATg and VATindex) in
women increased rapidly from age group 40–49 to age group
50–59, remained unchanged until age group 70–79, and
decreased thereafter (Figure 4). Percentiles of VAT% in
women increased across all age groups, with a steeper in-
crease from age group 40–49 to 50–59 (Figure 4).
In men, the pattern for VATg and VATindex 5th per-
centile was M-shaped across age groups (Figure 4). In the
25th and 50th percentiles, there was a small continuous in-
crease by age up to age group 70–79, while in the 75th and
95th percentiles, VATg and VATindex decreased from age
group 40–49 to 50–59, before it then increased up to age
group 70–79 and decreased thereafter. All percentiles for
VAT% increased over age groups in men, but the 75th and
the 95th percentile decreased after age 70–79 (Figure 4).
3.2. VAT and Metabolic Factors. Age-adjusted partial cor-
relation showed that VAT (all measurement units) was
positively associated with all cardiometabolic risk factors,
Table 2: Age-adjusted correlation for the association of VATg, VATindex, and VAT% with cardiometabolic risk factors: the Tromsø Study
2015–2016.
Cardiometabolic factors VATg VATindex VAT%
Women
Systolic blood pressure (mmHg) 0.12∗ 0.13∗ 0.10∗
Diastolic blood pressure (mmHg) 0.08∗ 0.08∗ 0.08∗
Triglycerides (mmol/L) 0.44∗ 0.44∗ 0.38∗
Total cholesterol (mmol/L) −0.006 −0.006 0.01
HDL cholesterol (mmol/L) −0.43∗ −0.43∗ −0.36∗
HbA1c (%) 0.24∗ 0.24∗ 0.17∗
CRP (mg/L) 0.14∗ 0.15∗ 0.09∗
Hypertension 0.20∗ 0.20∗ 0.15∗
Diabetes 0.23∗ 0.24∗ 0.16∗
Elevated triglycerides 0.35∗ 0.35∗ 0.31∗
Low HDL 0.28∗ 0.29∗ 0.24∗
Metabolic syndrome 0.29∗ 0.30∗ 0.24∗
Men
Systolic blood pressure (mmHg) 0.11∗ 0.11∗ 0.10∗
Diastolic blood pressure (mmHg) 0.13∗ 0.11∗ 0.12∗
Triglycerides (mmol/L) 0.38∗ 0.37∗ 0.31∗
Total cholesterol (mmol/L) −0.02 −0.03 −0.02
HDL cholesterol (mmol/L) −0.38∗ −0.37∗ −0.29∗
HbA1c % 0.27∗ 0.29∗ 0.19∗
CRP (mg/L) 0.08∗ 0.09∗ 0.03
Hypertension 0.25∗ 0.25∗ 0.21∗
Diabetes 0.22∗ 0.24∗ 0.18∗
Elevated triglycerides 0.34∗ 0.34∗ 0.28∗
Low HDL 0.25∗ 0.26∗ 0.20∗
Metabolic syndrome 0.30∗ 0.32∗ 0.23∗
∗P< 0.001.
Table 1: Descriptive of study population attending dual energy X-ray absorptiometry: the Tromsø Study 2015–2016.
Women (n� 2152) Men (n� 1523)
Age (years (% (n)) 66.2 (8.92) 65.9 (9.13)
40–49 5.95 (128) 6.70 (102)
50–59 13.2 (284) 12.3 (187)
60–69 43.3 (932) 47.4 (722)
70–79 32.1 (691) 27.5 (418)
80+ 5.44 (117) 6.17 (94)
Weight (kg) 71.3 (13.0) 86.0 (13.2)
Height (cm) 163.0 (6.25) 176.4 (6.70)
BMI (kg/m2) 26.8 (4.70) 27.6 (3.72)
VAT (g), mean (SD) 936.7 (632.5) 1660.9 (876.6)
VAT (g), median (25p–75p) 832 (444–1302.5) 1578 (1004–2222)
VAT (index), mean (SD) 0.35 (0.24) 0.53 (0.28)
VAT (index), median (25p–75p) 0.32 (0.16–0.49) 0.51 (0.33–0.71)
VAT (%), mean (SD) 37.1 (13.6) 60.2 (14.2)
VAT (%), median (25p–75p) 37.8 (28.3–46.7) 61.2 (52.0–69.9)
Presented as proportion (n) or mean (SD). VAT (all measurement units) is also presented as median with 25–75th percentile. VAT index: VATkg/height (m)2.
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except for HDL that was negatively associated with VAT,
and total cholesterol that was not significantly associated
(Table 2).
When comparing the ability of VATg, VATindex, and
VAT% to predict MetS and single MetS components, all
AUCs were high (≥0.67). AUCs of VATg and VATindex
were consistently higher than AUCs of VAT% (Table 3).
When comparing log likelihood/fit of age-adjusted
regression models by adding different VAT measurement
units to the model with MetS and single MetS components,
VATg and VATindex were the most important predictors
(Supplementary Table 5). C-statistics revealed no significant
differences between predictions of single MetS components
from the different VATmeasurement units (Supplementary
Table 6). In prediction of MetS, there were significant dif-
ferences by adding both VAT% and VATindex to the model
Table 3: AUC from different age-adjusted models with VAT (g), VAT (%), or VAT (index) in prediction of metabolic syndrome and single
metabolic components: the Tromsø Study 2015–2016.
Dependent variables
Women Men
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Hypertension 0.77 0.77 0.77 0.73 0.72 0.73
Diabetes 0.72 0.70 0.72 0.75 0.73 0.76
Elevated triglycerides 0.73 0.71 0.73 0.71 0.67 0.71
Low HDL 0.69 0.67 0.69 0.70 0.68 0.70
Metabolic syndrome 0.73 0.71 0.73 0.75 0.73 0.76
Independent: Model 1: age and VATg, Model 2: age and VAT%, Model 3: age and VATindex. Numbers indicating AUC for the model.
Table 4: Age-adjusted OR for the association of metabolic syndrome and single metabolic components and standardized/z-scores of VAT
mass in categories of body mass index (BMI): the Tromsø Study 2015–2016.
Metabolic
factors





































































































































































































Women: VATg SD: 632.5; VATindex SD: 0.24; VAT% SD: 13.6. Men: VATg SD: 876.6; VATindex SD: 0.28; VAT% SD: 14.2.
Table 5: Suggested threshold values of VATderived from Youden’s index and odds for metabolic syndrome: the Tromsø Study 2015–2016.
Women Men
(reshold OR (95% CI) Youden’s index (reshold OR (95% CI) Youden’s index
VAT (g) ≥1134 3.63 (2.94–4.49) 0.297 ≥1859 4.03 (3.17–5.13) 0.331
VAT (index) ≥0.44 4.04 (3.26–4.99) 0.321 ≥0.55 4.02 (3.15–5.13) 0.336
VAT (%) ≥40.3 3.36 (2.72–4.15) 0.298 ≥61.2 3.12 (2.44–3.97) 0.276
OR: odds ratio; CI: confidence interval.
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with VATg (P≤ 0.04 for both), but the AUCs were identical
in women and only slightly different in men (Supplementary
Table 6).
When investigating associations between z-score of VAT
(all measurement units) and MetS and single MetS com-
ponents in categories of BMI, the majority of associations
showed significantly higher odds with increasing VAT. (e
pattern showed highest odds for elevated triglycerides with
increasing VAT, in most categories of BMI in women, while
the odds for diabetes were highest in most categories of BMI
in men (Table 4). With regard to BMI differences, in women
the highest odds for hypertension and elevated triglycerides in
all z-score units of VAT were observed in the overweight
category and the highest odds for diabetes, low HDL cho-
lesterol, and MetS were observed in the obese category. (e
only exception was z-scores of VATindex in association with
low HDL cholesterol which was highest in the overweight
category (Table 4). In men, the highest odds for MetS and all
MetS components were observed in the overweight category
according to all z-score units of VAT (Table 4). (e different
z-score units of VAT and associations with MetS and MetS
components were similar, although higher odds were observed
in z-scores of VATg and VATindex compared to VAT%.
Based on Youden’s index and the abilities to predict MetS,
suggested thresholds of VATg, VATindex, and VAT% in
women are ≥1134, ≥0.44, and≥ 40.3, respectively, with
corresponding odds for MetS of 3.63, 4.04, and 3.36, re-
spectively. In men, suggested thresholds and odds for MetS
were ≥1859 (OR: 4.03), ≥0.55 (OR: 4.02), and ≥61.2 (OR:
3.12), for VATg, VATindex, and VAT%, respectively
(Table 5).
4. Discussion
Measures of VAT (expressed in absolute and derived variables)
were positively associated with age, MetS, and single MetS
components. VATg and VATindex consistently showed slightly
stronger associations with MetS and single MetS components
than VAT%, but overall, the associations were similar.
Because the distribution of fat, and especially VAT ac-
cumulation in abdominal area, rather than overall fat mass
has been highlighted as the most robust predictor for car-
diometabolic disease, it is valuable to determine reference
values for VAT [17]. Relative measures (e.g., waist-to-height
ratio) may be stronger predictors for disease than absolute
measures (e.g., waist circumference) [18, 19], and it is
therefore also relevant to assess whether relative measures of
VATaremore strongly correlated withMetS and singleMetS
components than absolute measures.
We observed higher VATg in percentiles for both
women and men as compared to other studies [9, 10].
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Figure 2: Normality curves of VAT (g), VAT (index), and VAT (%).
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years) and Hirsch et al. [10] used the next-generation DXA
(iDXA), in addition to presenting different age groups than
us (25–49 years and 50+ years), thus limiting direct com-
parison of results.
Our age-adjusted partial correlations were similar to
those found by Rothney et al. [12], who used the iDXA
system to study associations between VATg and
cardiometabolic risk factors. Miazgowski et al. [9] found
stronger correlations between VATg and cardiometabolic
risk factors, than in our analysis, but the AUCs observed in
the present study are higher. Miazgowski et al. [9] did,
however, not adjust for age and presented cardiometabolic
risk factors in different units than the present study; thus






































































































































































































Figure 3: VAT (g, index, and %) and subcutaneous fat (g) in android region over age: the Tromsø Study 2015–2016.
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VATg and VATindex decreased rapidly after the age of
70 years. A similar decrease in VAT after age 70 years was
found in a study from the United States (using iDXA) [8],
which suggested that this decrease could be explained by the
small number of participants in the oldest population. (is
decreasing pattern after age 70 was, however, not confirmed
by a larger population-based study (n= 10 984) from
Ofenheimer et al. [7], conducted in Austria using the system
Lunar Prodigy system. Among our participants, 1320 (61%
women) were 70 years and older, and together with a high
attendance among the older population in the Tromsø Study
[20], we conclude that the decrease presented in this study
cannot be explained by low participation. Although we did
not have the opportunity to investigate potential anthro-
pometric differences in nonattenders, we did compare the
population only attending basic examinations, with those
also attending extended examinations (DXA) and found no
clinically or statistically significant differences in BMI or
waist circumference. Previous studies investigating longi-
tudinal change in BMI and waist circumference in the
Tromsø Study population showed that adiposity increases
with age, with a larger increase in the younger compared to
the older birth cohorts [21–23]. One might hypothesize that
central adiposity is less prevalent in the older than younger
age groups in the present population. Body composition
changes with age as total lean mass decreases, fat mass
increases, and a greater proportion of fat accumulates within
the abdomen as visceral fat [24]. (is was reflected in the
present study as VAT% (particularly in women) increased
continuously, while VATg decreased after age 70. (is ob-
servation is due to VATg decreasing relatively less than
subcutaneous fat. A somewhat surprising finding was the
steep decline in subcutaneous fat in women older than 70
years, compared to the linear decrease observed in men.
All cardiometabolic risk factors except total cholesterol
showed statistically significant associations with VAT.
Similar findings were observed in previous studies inves-
tigating the associations between DXA-derived VAT and
cardiometabolic risk factors [9, 12, 25]. We could, however,
find no other studies comparing how the different mea-
surement units of VATperformed in their associations with
MetS and single MetS components. Further, the threshold
values were higher for men than women. Although one
might expect absolute threshold values to be higher for
men, it is quite interesting that the relative measures are
also higher, indicating that men might tolerate a higher
amount of VAT relative to body size before it becomes a
risk for MetS.
To the best of our knowledge, this is the first study pre-
senting reference values for VATindex and VAT% in addition
to suggested threshold values for VAT (all units) in association
with MetS. (erefore, the results presented are of importance
to future studies utilizing DXA-derived VATand may support
clinicians, who use DXA in their daily routine, to make de-
cisions on whether to initialize interventions for patients with
abdominal obesity. Although previous studies have presented
reference values for VAT in grams, it is highly important to
complement previous proposed reference values and also to
present reference values for measures that address VAT in
relation to overall body size (VATindex andVAT%). It has long
been known that VAT is of particular concern to car-
diometabolic health, and tracking VAT as a representative for
overweight and obesity is a more accurate indicator of the
health status than traditional anthropometric measures such as
BMI or waist circumference. (e current study enables
comparison with future studies aiming at presenting reference
values and threshold values of VAT. We emphasize that the
reference values and thresholds presented are applicable only to
similar populations andmeasures from similar equipment as in
the present study. Future studies are needed to confirm the
thresholds suggested in our population.
4.1. StrengthsandLimitations. Amajor strength of this study
is the wide age range of participants, providing proposed
VAT reference values in adults aged 40 and older. Further,
we could investigate VAT’s association with both MetS and
single MetS components and propose threshold values for
VAT (all units) based on sensitivity and specificity in pre-
diction of MetS. Because of the population-based design,
where fasting blood samples are unusual, we did not include
fasting glucose as an indicator for diabetes, but rather self-
reported diabetes, medication use, or HbA1c≥ 6.5% which
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Figure 4: Quantities of VAT (g), VAT (index), and VAT (%) in 10-year age groups in women and men: the Tromsø Study 2015–2016.
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diabetes. We did not have the opportunity to examine
whether the study participants differed from nonattenders.
We did however compare those attending only the basic
examination of the survey to those included in this analysis
and found no differences according to waist circumference
or BMI, and together with the high attendance we conclude
that our study is representative of the general population. It
should be emphasized that the references derived here (from
Lunar Prodigy in age group 40–84 in a Norwegian pop-
ulation) may not be directly comparable to reference values
derived from other manufacturers, DXA equipment, age
groups, or populations/ethnicities, but to similar pop-
ulations and methods used in the current study.
5. Conclusions
DXA-derived VATg and VATindex increased with age up to
70 years, while VAT% increased continuously with age. (e
percentiles presented (5th, 12th, 50th, 75th, and 95th) and
suggested thresholds of VATg, VATindex, and VAT% can be
used for comparison with studies of similar populations
using the same technology. All VAT measurement units
except total cholesterol showed statistically significant as-
sociations with cardiometabolic risk factors. Results did not
substantially differ between measurements units of VAT;
thus, any measurement unit seems acceptable to use.
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Abstract
Background: Body mass index (BMI) increases while cardiometabolic risk factors
decrease in individuals in high‐income countries. This paradoxical observation raises
the question of whether current measures of overweight and obesity properly
identify cardiometabolic risk.
Methods: A total of 3675 participants (59% women) aged 40–84 years with whole‐
body dual‐energy x‐ray absorptiometry scans from the seventh survey of the
Tromsø Study were included to examine the association between visceral adipose
tissue (VAT) in grams and BMI, waist circumference (WC), waist‐to‐hip ratio (WHR),
and waist‐to‐height ratio (WHtR). Further, their association with single car-
diometabolic risk factors (blood pressure, triglycerides, total cholesterol, high‐
density lipoprotein [HDL] cholesterol, glycated hemoglobin, high‐sensitivity
C‐reactive protein), modified single components from the ATP Ⅲ criteria for
metabolic syndrome (hypertension, diabetes, high triglycerides, and low HDL
cholesterol), and metabolic syndrome were examined.
Results: VAT mass was strongly correlated with BMI (r ≥ 0.77), WC (r ≥ 0.80), WHR
(r ≥ 0.58), and WHtR (r ≥ 0.78). WC was the strongest predictor for VAT (area
under the curve: 0.90). Compared to anthropometric measures, the associations
between VAT and metabolic syndrome as well as single components of metabolic
syndrome were statistically significantly stronger, but the clinical differences were
likely minor.
Conclusion: Although VAT mass showed statistically stronger associations with
cardiometabolic risk compared to traditional anthropometrics, the clinical impor-
tance was likely small. Simple, clinically available tools seem to satisfactory
substitute for VAT to identify cardiometabolic risk.
K E YWORD S
cardiometabolic health, dual energy x‐ray absorptiometry, obesity, overweight, population
studies, visceral adipose tissue
© 2021 The Authors. Obesity Science & Practice published by World Obesity and The Obesity Society and John Wiley & Sons Ltd.
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1 | INTRODUCTION
The global obesity prevalence has tripled in the last 4 decades, and
more than 2.8 million deaths per year can be attributed to over-
weight and obesity.1 Simultaneously, in high‐income countries, there
has been a decline in other cardiometabolic risk factors including
total cholesterol2 and blood pressure,3 and in the overall burden of
cardiovascular disease.4–6 This paradox questions whether the
current definition of overweight and obesity properly identifies
cardiometabolic risk.
Traditionally, overweight and obesity are categorized by simple
clinically available anthropometric measures including body mass
index (BMI) or waist circumference (WC). The relevance of BMI has
been questioned,7,8 and WC has its limitations related to measure-
ment error, that is, correct placement of measurement tape. Other
measures, hypothesized to be more accurate in defining obesity
compared to BMI and WC, are waist‐to‐hip ratio (WHR) and waist‐
to‐height ratio (WHtR).9,10 However, none of these measures
distinguish fat mass from fat‐free mass, thus do not directly address
the definition of overweight and obesity as “abnormal or excessive
fat accumulation that may impair health.”1
Magnetic resonance imaging (MRI) and computed tomography
(CT) are considered the most accurate assessment tools of body
composition; however, they are resource demanding.11 Visceral adi-
pose tissue (VAT) from dual‐energy x‐ray absorptiometry (DXA) is
highly correlated with the corresponding measures from MRI and
CT.12,13 VAT, located intra‐abdominally and around the organs, is
more metabolically active than subcutaneous fat and is linked to in-
sulin resistance, metabolic syndrome, cardiovascular disease, and
several types of cancer.14 Therefore, the current study hypothesized
that DXA‐derived VAT might be a clinically more important marker
than anthropometric measures when investigating the association
between body composition and cardiometabolic disease risk. How
DXA‐derived VAT performs against anthropometric measures in the
association with cardiometabolic risk factors is currently unknown, as
the most previous studies investigating such differences used other
measurement methods to derive VAT.15–20
The aim of this study was to investigate whether DXA‐derived
VAT is more strongly associated with cardiometabolic risk than
traditional anthropometric measures, using a large population‐based
sample of middle‐aged and older adults.
2 | MATERIAL AND METHODS
2.1 | Sample
The Tromsø Study21 is an ongoing population‐based study consisting
of seven surveys (Tromsø 1–7) conducted from 1974 to 2016,
inviting large representative samples of the population in the Tromsø
municipality in Norway. In the seventh survey (2015–2016), all in-
habitants, 40 years and older, were invited (n = 32,591). A selected
sub‐sample (n = 13,028) was invited to extended examinations about
2 weeks after attending the basic examination. This sub‐sample
included a randomized sample (n = 9925) in addition to partici-
pants previously attending DXA, echocardiogram, and eye examina-
tions in Tromsø 6 (2007–2008) (n = 3103). A total of 21,083 (65%)
participants aged 40–99 years attended the basic examination, and
8346 attended the extended examinations (of those attending
extended examinations, this equaled 64% of the initially selected
sub‐sample). Among those attending basic examinations, 5232
participants were invited to DXA scans and 3683 (70%) attended
whole‐body DXA scans. Eight participants were excluded because of
incorrect placement in the DXA machine, resulting in the CoreScan
application being unable to calculate VAT in the abdominal area.
Therefore, 3675 participants with VAT measures were included in
the analysis (Figure 1).
This project was approved by the Regional Committee for
Medical Research Ethics (REC North ref. 2017/1967), and all par-
ticipants gave written informed consent.
2.2 | Cardiometabolic risk factors and metabolic
syndrome components
Information about self‐reported diabetes, use of antidiabetics (insulin
or tablets), lipid‐lowering drugs, and antihypertensives from self‐
administered questionnaires was included. Trained technicians per-
formed all examinations using standard protocols. Non‐fasting blood
samples were analyzed at the Department of Laboratory Medicine at
the University Hospital of North Norway (ISO certification NS‐EN
ISO 15189:2012) for total cholesterol (mmol/L), high‐density
lipoprotein (HDL) cholesterol (mmol/L), triglycerides (mmol/L),
high‐sensitivity C‐reactive protein (hs‐CRP, mg/L), and glycated
hemoglobin (HbA1c, %). Systolic and diastolic blood pressures were
measured three times with 2‐min intervals with a Dinamap ProCare
300 monitor (GE Healthcare), and the mean of the two last readings
was used in the analyses. Single cardiometabolic risk factors (WC and
fasting glucose excluded) were defined based on the National
Cholesterol Education Program Adult Treatment PanelⅢ (NCEP ATP
III) diagnostic components for the metabolic syndrome (2005 revi-
sion)22: hypertension (systolic blood pressure >130 mmHg and/or
diastolic blood pressure >85 mmHg and/or use of antihypertensives)
(n: 2498 [57% women]), high non‐fasting triglycerides (triglycerides
≥1.7 mmol/L and/or use of lipid‐lowering drugs) (n: 1659 [52%
women]), low HDL cholesterol (HDL cholesterol <1.3 [women] or
<1.0 [men] mmol/L and/or use of lipid‐lowering drugs) (n: 1164 [57%
women]), and diabetes (self‐reported diabetes and/or HbA1c ≥ 6.5%
and/or use of antidiabetics) (n: 311 [54% women]). Metabolic syn-
drome (MetS) was defined as the presence of three or more of the
metabolic syndrome components presented above, as defined by
NCEP ATP III (n: 493 [24%] women and 406 [28%] men). Waist
circumference was excluded from the definition of MetS because it
was included in the study for comparison to VAT.
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2.3 | Measures of adiposity
Body weight and height were measured with light clothing and no
shoes to the nearest 0.1 kg and nearest 0.1 cm, respectively, using a
Jenix DS‐102 height and weight scale (DongSahn Jenix). BMI was
calculated as weight divided by height squared (kg/m2). WC and hip
circumference were measured to the nearest 0.1 cm with a Seca
measurement tape at the level of the umbilicus and the greater
trochanters, respectively. BMI, WC, WHR (WC divided by hip
circumference, cm/cm), and WHtR (WC divided by height, cm/cm)
were included as continuous variables for association with VAT.
Whole‐body DXA scans were performed with a Lunar Prodigy
Advance (GE Healthcare) according to guidelines from the manu-
facturer, and trained technicians inspected the post‐scan images.
The DXA device was calibrated each morning with a phantom
before starting measurements. The CoreScan application (EnCore
version 17.0) was used to compute VAT from DXA scans, and VAT
in grams (g) and volume (cm3) were included. Both VAT volume and
VATindex (VAT [g] divided by height squared [g/m2]) were highly
correlated (r: 1.00 and 0.99, respectively) with VAT mass (g).
Therefore, only VAT mass was included for further analyses in the
present study.
2.4 | Statistical analyses
The software of the DXA machine is not sensitive enough to detect
extremely low VAT values. Thus, we chose to transform VAT mass
F I GUR E 1 Inclusion of study participants: The Tromsø Study 2015–2016. DXA, dual‐energy x‐ray absorptiometry; VAT, visceral adipose
tissue
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with values of 0 (n = 10) into the lowest value (2 g) measured in the
overall sample. Descriptive analyses, Student's t‐test for comparison
of means, and Wilcoxon rank‐sum test for comparison of median
were used to present the study population characteristics (Table 1).
To display the correlation between VAT and anthropometric mea-
sures, Pearson's correlation coefficients (r) in 10‐year age groups
were presented (Table 2). Age‐adjusted partial correlations were
used to investigate correlations between VAT, anthropometric
measures, and cardiometabolic risk factors (Table 3). Although the
cross‐sectional design of this study makes it difficult to establish
causal pathways, receiver operating characteristics (ROC) analyses
were performed to investigate the ability of VAT and anthropometric
measures to predict MetS and single metabolic syndrome compo-
nents (Figure 2). Area under the curves (AUCs) with confidence in-
tervals (CIs) are presented. In addition, c‐statistics was applied to
compare the age‐adjusted AUCs between VAT mass and the
anthropometric variables in predicting MetS and single metabolic
syndrome components (Table 4). Finally, to investigate which of the
anthropometric measures that best predict VAT, VAT was dichoto-
mized in two groups (at median), and the results from ROC analysis
of VAT in relation to BMI, WC, WHR, and WHtR are presented
(Figure 3). All analyses were performed separately in women and
men. STATA 14 (STATA Corp LP) was used for all analyses.
3 | RESULTS
Of the 3675 participants with whole‐body DXA scans, 3672, 3666,
and 3664 also had valid BMI, WC/WHR, and WHtR measures,
respectively (Figure 1). Mean age was similar in women and men
(66.2 and 65.9 years, respectively). Men had higher mean values of
VAT and anthropometric measures than women (Table 1). Mean
values of BMI were in the overweight bracket for both women and
men, and according to mean values of WC, women were at very high
risk and men at high risk for cardiometabolic disease (Table 1). In
women. 66% had hypertension, 8% diabetes, 41% high triglycerides,
TAB L E 1 Descriptive of study
population attending part 2: The Tromsø
Study 2015–2016
Women (n = 2152) Men (n = 1523) p‐value
Age (years) 66.2 (8.92) 65.9 (9.13) 0.35
40–49 5.95 (128) 6.70 (102) 0.54
50–59 13.2 (284) 12.3 (187) 0.55
60–69 43.3 (932) 47.4 (722) 0.46
70–79 32.1 (691) 27.5 (418) 0.21
80+ 5.44 (117) 6.17 (94) 0.36
Weight (kg) 71.3 (13.0) 86.0 (13.2) <0.001
Height (cm) 163.0 (6.25) 176.4 (6.70) <0.001
BMI (kg/m2) 26.8 (4.70) 27.6 (3.72) <0.001
Waist (cm) 91.2 (12.4) 100.5 (10.5) <0.001
WHR (cm/cm) 0.88 (0.08) 0.97 (0.07) <0.001
WHtR (cm/cm) 0.56 (0.08) 0.57 (0.06) <0.001
VAT (g)—mean (SD) 936.7 (632.5) 1660.9 (876.6) <0.001
VAT (g)—median (25p–75p) 832 (444–1302.5) 1578 (1004–2222) <0.001
Hypertension (%[N]) 66.2 (1415) 71.7 (1083) <0.001
Diabetes (%[N]) 8.05 (168) 9.67 (143) 0.09
High triglycerides (%[N]) 41.1 (864) 53.1 (795) <0.001
Low HDL cholesterol (%[N]) 31.7 (666) 33.5 (498) 0.97
Metabolic syndrome (%[N]) 24.0 (493) 27.8 (406) 0.01
Notes: Presented as proportion (n) or mean (SD). VAT mass is also presented as median with 25‐75%
percentile. Student's t‐test was used to compare means and Wilcoxon rank‐sum was used to
compare medians. Chi‐square test was used to compare proportions.
Among participants categorized as having low HDL (666 women and 498 men), 395 (59%) women
and 351 (71%) was due to use of lipid‐lowering medication, not low HDL levels <1.3 (women) or
<1.0 (men).
There are minor differences in number of participants according to different variables included.
Abbreviations: BMI, body mass index; VAT, visceral adipose tissue; SD, standard deviation; p,
percentile; WHR, waist‐to‐hip ratio; WHtR, waist‐to‐height ratio.
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32% low HDL cholesterol, and 24% had MetS. In men, 72% had hy-
pertension, 10% diabetes, 53% high triglycerides, 34% low HDL
cholesterol, and 28% had MetS (Table 1).
3.1 | Correlations between VAT mass and
anthropometric variables
Table 2 shows that the age‐specific correlations between VAT and the
anthropometrics were all relatively high, although somewhat lower in
women than in men, and lower in older adults. The strongest age‐
specific correlations in both women and men were observed be-
tween VAT and WC (r: 0.69–0.84 and 0.79–0.88 in women and men,
respectively) and the weakest correlation between VAT and WHR (r:
0.43–0.64 and r: 0.63–0.72 in women and men, respectively) (Table 2).
3.2 | Associations with cardiometabolic risk, single
metabolic syndrome components, and MetS
VAT and anthropometrics were consistently associated with all car-
diometabolic risk factors (Table 3), except for total cholesterol.
However, the correlations were low (r < 0.3) for most associations
except for HDL cholesterol and triglycerides that were moderately
correlated (both r: ≥0.3) to VAT and the anthropometric measures.
Based on the ROC analyses (Figure 2), VAT was not superior to
the anthropometric variables in predicting hypertension or diabetes
in women nor men, nor low HDL cholesterol in men. VAT was a
stronger predictor for high triglycerides than BMI (AUC 95% CI: 0.72
[0.70–0.75] vs. 0.65 [0.63–0.67] in women, and 0.71 [0.68–0.73] vs.
0.65 [0.63–0.68]) in men). Also, VAT was a stronger predictor than
BMI for low HDL cholesterol in women (AUC 95% CI: 0.68
TAB L E 2 Pearson's correlation coefficients of VAT with
anthropometrics in 10‐year age groups: The Tromsø Study 2015‐
2016
BMI (kg/m2) WC (cm) WHR (cm/cm) WHtR (cm/cm)
Women 0.77 0.80 0.58 0.78
40–49 0.75 0.80 0.61 0.77
50–59 0.83 0.84 0.64 0.83
60–69 0.76 0.80 0.58 0.78
70–79 0.77 0.79 0.53 0.76
80+ 0.70 0.69 0.43 0.60
Men 0.78 0.82 0.69 0.79
40–49 0.87 0.88 0.64 0.85
50–59 0.74 0.79 0.70 0.77
60–69 0.81 0.84 0.72 0.79
70–79 0.78 0.79 0.64 0.76
80+ 0.73 0.81 0.63 0.76
Note: All associations were significant with p‐value <0.001.
Abbreviations: BMI, body mass index; VAT, visceral adipose tissue; WC,
waist circumference; WHR, waist‐to‐hip ratio; WHtR, waist‐to‐height
ratio.
TAB L E 3 Partial* correlations between VAT, BMI, WC, WHR, WHtR, and cardiometabolic risk factors. The Tromsø Study 2015–2016
Women VAT (g) BMI (kg/m2) WC (cm) WHR (cm/cm) WHtR (cm/cm)
Systolic blood pressure (mmHg) 0.12 0.15 0.15 0.12 0.16
Diastolic blood pressure (mmHg) 0.08 0.07 0.09 0.08 0.08
Triglycerides (mmol/L) 0.44 0.33 0.37 0.33 0.29
Total cholesterol (mmol/L) −0.006 −0.01 −0.02 0.006 −0.02
HDL cholesterol (mmol/L) −0.43 −0.36 −0.37 −0.29 −0.39
HbA1c (%) 0.24 0.16 0.19 0.17 0.20
hs‐CRP (mg/L) 0.14 0.16 0.14 0.09 0.16
Men VAT (g) BMI (kg/m2) WC (cm) WHR (cm/cm) WHtR (cm/cm)
Systolic blood pressure (mmHg) 0.11 0.09 0.10 0.08 0.10
Diastolic blood pressure (mmHg) 0.13 0.10 0.12 0.10 0.09
Triglycerides (mmol/L) 0.38 0.30 0.31 0.31 0.27
Total cholesterol (mmol/L) −0.02 −0.009 −0.009 −0.02 −0.004
HDL cholesterol (mmol/L) −0.38 −0.34 −0.36 −0.31 −0.34
HbA1c (%) 0.27 0.23 0.23 0.24 0.26
hs‐CRP (mg/L) 0.08 0.08 0.10 0.12 0.10
Note: All correlations, were significant <0.001, except for total cholesterol (p‐value: 0.41–0.80 and 0.33–0.88 in women and men, respectively).
Abbreviations: BMI, body mass index (kg/m2); HDL, high‐density lipoprotein; hs‐CRP, high‐sensitivity C‐reactive protein; mmol, millimole; mmHg,
millimeters of mercury; VAT, visceral adipose tissue; WC, waist circumference; WHR, waist‐to‐hip ratio; WHtR, waist‐to‐height ratio.
*Age‐adjusted.
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F I GUR E 2 Comparison of BMI, WC, WHR, WHtR, and VAT in predicting diabetes, hypertension, high triglycerides, and low HDL
cholesterol: The Tromsø Study 2015–2016. BMI, body mass index; HDL, high‐density lipoprotein; VAT, visceral adipose tissue; WC, waist
circumference; WHR, waist‐to‐hip ratio; WHtR, waist‐to‐height ratio
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[0.66–0.71] vs. 0.63 [0.60–0.65]). For prediction of MetS, VAT was
stronger than BMI in both women and men (AUC 95% CI: 0.71 [0.68–
0.73] vs. 0.64 [0.61–0.67] in women, and 0.70 [0.67–0.73] vs. 0.63
[0.59–‐0.66]) in men).
Comparison of AUCs between age‐adjusted models with VAT
and age‐adjusted models with anthropometrics showed that VAT was
a stronger predictor than all anthropometric measures (although only
borderline significantly better than WHtR) to predict hypertension in
men (Table 4). To predict diabetes, VAT was significantly stronger
than BMI and WC in both men and women. VAT was significantly
stronger than all anthropometrics to predict high triglycerides in both
women and men (Table 4). In the prediction of low HDL cholesterol,
VAT was stronger than BMI, WC, and WHtR in women and stronger
than all anthropometrics in men. Finally, to predict MetS, VAT was in
women stronger than BMI and WC, and borderline significantly
stronger than WHtR. In men, VAT was stronger than all anthropo-
metrics in the prediction of MetS (Table 4).
3.3 | Associations between the different
anthropometric parameters with VAT mass
The ROC curves in Figure 3 show that all anthropometrics were
strong predictors of VAT (AUC > 0.80). WC was the strongest pre-
dictor (AUC: 0.90), while the AUCs for WHR were the weakest (0.82
and 0.84, in women and men, respectively).
4 | DISCUSSION
In this analysis of 3675 middle‐aged and older adults, we found that
VAT was moderately to strongly correlated with all included anthro-
pometric measures. The correlation between DXA‐derived VAT
measures and anthropometric measures is well established,23–25 but
previous studies include narrower age ranges (29–55 years)20,23,25
or smaller samples (81–939 participants).12,20,23,24 Thus, together
with the additional ROC analysis and comparison with MetS and
single metabolic syndrome components, the current study is an
important contribution for establishing if DXA‐derived VAT has
clinical importance over and above traditional anthropometric risk
factors to predict cardiometabolic risk. The association between
anthropometric measures and VAT derived from CT or MRI,16,19,26,27
ultrasound,15 and bioelectrical impedance17,18 has previously been
investigated. Although CT and MRI are considered the most accurate
techniques to quantify body composition, neither are suitable for
population studies,11 and because DXA‐derived VAT is highly
correlated with VAT measured by CT and MRI, it is considered
a preferable substitute for the more resource‐demanding
measures.12,13
The presented ROC curves showed that among the anthropo-
metric measures, WC had the strongest association with VAT; how-
ever, no other studies confirming this result were found. A previous
study using DXA found that WHtR was the best anthropometric
predictor for VAT, although closely followed by WC.20 However, this
study was based on a small sample (n = 81) with younger participants
(mean age = 38.4) than the present study, which makes comparison
challenging.20 The high correlation between VAT and WC is consid-
ered as reasonable, as they are both measures from approximately
the same area in the abdominal region. However, all anthropometric
measures were considered strong predictors of VAT with high AUCs
(≥0.82), and it is reasonable to assume that they all serve as satis-
factory substitutes for VAT.
Although the correlations between VAT and all anthropometrics
were overall moderate to strong, they were weakest in the oldest
age group. This might be explained by changes in body composition
with increasing age, where VAT mass increases relative to the
F I GUR E 3 Comparison of VAT with anthropometric variables: The Tromsø Study 2015–2016. *VAT mas cut at median: women ≤832 or
>832, men ≤1578 or >1578. BMI, body mass index; VAT, visceral adipose tissue; WC, waist circumference; WHR, waist‐to‐hip ratio; WHtR,
waist‐to‐height ratio
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abdominal subcutaneous fat mass.28,29 It has been observed that
subcutaneous fat decreases rapidly after the age of 70 years, while
VAT does not have the same steep decline.30 Additionally, WC has
been reported to be a satisfactory surrogate for VAT in adults, but
not in older adults.19 The age difference in body composition could
potentially be explained by the change in sex hormones and in
physical activity levels among the elderly.19 Thus, conventional
anthropometric measurements might not properly capture the
changes in body composition that occurs with increasing age. This
emphasizes the need for more accurate adiposity measurements in
the older age groups.
VAT mass and anthropometric measures had similar associa-
tions and correlations to the cardiometabolic risk factors. The
correlations were higher for triglycerides and HDL cholesterol
compared to the other cardiometabolic risk factors. Although VAT
was statistically significantly better than anthropometrics in the
prediction of single metabolic risk factor components and MetS,
the clinical differences were likely minor given the similar AUCs.
Thus, the anthropometric measures are considered as satisfactory
substitutes for VAT.
VAT was more strongly associated with high triglycerides
compared to the anthropometric measures, which corresponds to
the findings from a previous study.23 Although VAT AUCs
were significantly higher for several of the single metabolic syn-
drome components and MetS (Table 4), the clinical differences are
likely small given the proximity between AUCs for VAT and
anthropometric variables (e.g., the lowest AUC for MetS was 0.642
for BMI compared to 0.705 for VAT in women). Although VAT is
statistically more accurate, the more accessible and less resource‐
demanding clinical measurements show similar predictive abili-
ties of cardiometabolic risk factors and metabolic syndrome
components. Longitudinal study designs and intervention
studies are needed to investigate the potential differences
between VAT and anthropometric measures and their associa-
tion with incidence of metabolic syndrome and cardiometabolic
disease.
4.1 | Strength and limitations
There are several strengths of this study. First, a large population‐
based sample with a wide age range of adults and older women
and men was included. Second, all examinations and all definitions
in the current analysis are performed and created by standard
criteria, thus enabling comparison with future studies. Further,
when performing DXA scans, the technicians were given stan-
dardized training and used protocols according to the manufac-
turer's recommendation. Also, all scans were inspected post‐
measurement, and regions of interest were adjusted to ensure
standardization between participants. However, measurement er-
ror in DXA scans is a potential limitation.31 The accuracy of VAT
measured by DXA decreases with increasing BMI.31 As about 46%
and 22% of our study sample were overweight and obese,
respectively, a measurement error may occur and is difficult to
detect. Another limitation is that the cross‐sectional design limits
our possibility to study whether anthropometric measures are
equally good as VAT to predict future health.
5 | CONCLUSION
VAT mass showed moderate to high correlations with all included
anthropometric measures. The strongest association was observed
between VAT and WC. Although VAT was a statistically more ac-
curate predictor of single metabolic syndrome components and MetS,
the clinical difference compared to the anthropometric variables was
small given the similar AUCs. The conclusion from this study is that
anthropometric measures are satisfactory substitutes to VAT in
identifying cardiometabolic risk.
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Study importance questions: 
- What is already known about this subject?  
• Overall overweight and obesity, usually measured by BMI, are increasing all around the world, and no efforts 
has shown to be effective in halting this trend. 
• BMI is a proxy measure of overweight and obesity, which does not address the actual definition of overweight 
and obesity which is “excessive fat accumulations that may impair health”. Knowledge about trends in body 
composition and especially trends in the most harmful fat (visceral fat) is lacking. 
 
- What are the new findings in your manuscript? 
• Our manuscript contributes with new knowledge about secular and longitudinal trends in body composition, 
and more specifically body fat, visceral fat and lean mass, in a general adult population with a follow-up of 15 
years. 
• No other studies have presented trends in DXA-derived visceral adipose tissue in a general population.  
 
- How might your results change the direction of research or the focus of clinical practice? 
• We believe that our results are of importance to both researchers, clinicians and public health workers, as a 
motivation to enhance the battle against the obesity epidemic and especially targeting the younger generations 










Objective: Overweight, defined as excessive fat mass, is a long-standing worldwide public health challenge. 
Traditional anthropometric measures used to identify overweight and obesity do not assess body composition. Our aim 
was to study population trends in general and abdominal fat mass during the last two decades.  
Methods: We included participants from one or more consecutive surveys of the population-based Tromsø Study; 
Tromsø 5 (conducted in 2001, n=1662, 40-84 years), Tromsø 6 (2007-2008, n=901, 40-88 years) and Tromsø 7 (2015-
2016, n=3670, 40-87 years) with total body dual-energy x-ray absorptiometry (DXA) scans. Trends in total fat and 
visceral adipose tissue (VAT) were analyzed by generalized estimation equation models, in strata of sex and age-
groups. 
Results: Total fat and VAT mass increased during 2001-2016, with a larger increase during 2007-2016 than from 
2001 to 2007, and among the youngest age-group (40-49 years), particularly in women. Women had higher total fat 
mass than men, while men had higher VAT mass than women.  
Conclusions: General and abdominal DXA-derived fat mass increased during the last two decades in this general 
population. Of particularly concern is the more pronounced increase in the last decade, and in the younger age-groups.  
 
Introduction 
The obesity epidemic cause concern in all parts of the world, and almost 40% of the adult population worldwide had 
overweight in 2016 according to the World Health Organization (WHO) (1). Obesity and overweight are major risk 
factors for non-communicable diseases, including cardiovascular diseases, which is the leading cause of death globally 
(2).  
The definition of overweight and obesity is “abnormal or excessive fat accumulation that may impair health” (1). 
Anthropometric measures such as body mass index (BMI) (weight in kilograms divided by body height in meters 
squared [kg/m2)]) and waist circumference are currently the most frequently used measures of general and abdominal 
overweight and obesity, in lack of more precise but available methods. BMI and waist circumference do not 
distinguish between fat mass and fat free mass, thus is not directly addressing the definition of obesity. Increased BMI 
indicates either increased muscle mass and/or increased fat mass, which have different effects on health. Most 
previous studies have used BMI to present increasing prevalence of overweight and obesity, but it is unknown whether 
body composition has changed over time.  
 
There are several tools to examine body composition. The more accurate such as magnetic resonance imaging (MRI) 
and computed tomography (CT) are expensive, resource-demanding or involve considerable radiation exposure (3). 
Dual-energy x-ray absorptiometry (DXA) is a clinically applicable imaging method with negligible radiation exposure 
that also provides accurate measures of body fat, bone and lean tissue (i.e., muscle and organs, bone and fat excluded) 
(3). In addition, the CoreScan application (EnCore version 17.0) enables computation of visceral adipose tissue (VAT) 
from DXA scans, which is highly correlated with VAT derived from MRI and CT (4, 5). VAT, located intra-
abdominal and around organs, is regarded as the most metabolically active body fat component, and has been 
associated with cardiometabolic diseases and several types of cancers (6). Previous studies investigating DXA-
measured changes in body composition mainly included older adults (≥ 65 years) and had short follow-up (≤ 5 years) 
(7-12). To our knowledge, no studies have examined both secular and longitudinal changes in body composition and 
VAT mass in a general adult population sample measured by DXA. 
 
The aim of this study was to examine trends in body composition during the last two decades using a population-based 
sample.  
Methods 
Study Sample  
The Tromsø Study is an ongoing population-based study (13) conducted in Tromsø municipality, a municipality with 
about 77 000 inhabitants in Northern Norway (14). The majority of the population is native Norwegian and similar to 
the general Norwegian population in regard to age and sex (14). The Tromsø Study consists of seven surveys; Tromsø 
1 (conducted in 1974), Tromsø 2 (1979-1980), Tromsø 3 (1986-1987), Tromsø 4 (1994-1995), Tromsø 5 (2001), 
Tromsø 6 (2007-2008), Tromsø 7 (2015-2016), inviting complete birth cohorts and large representative samples of the 
population in Tromsø municipality in Norway. The present study includes participants from Tromsø 5-Tromsø 7 
(2001-2016). The data collections comprised a basic examination (total sample) with questionnaires and interviews, 
biological sampling and clinical examinations, and an extended examination (subsamples) with additional clinical 
examinations, including DXA scanning. The subsamples invited to the extended examination varied between studies; 
in Tromsø 5 (total number of participants in the basic examination=8130, 30-89 years, total attendance 79%) all 
participants attending basic examination in Tromsø 5 and had previously attended the extended examinations in 
Tromsø 4 were invited; in Tromsø 6 (total n=12 984, 30-87 years, total attendance 66%) all participants who attended 
extended examinations in Tromsø 4, all participants aged 50-62 years and 75-84 years, plus a 20% random sample 
aged 63-74 years were invited to the extended examinations; and in Tromsø 7 (total n=21 083, 40-99 years, total 
attendance 65%) a random sample plus all participants attending DXA and eye examinations in Tromsø 6 were invited 
to extended examinations.  
A total of 1713, 905 and 3670 participants underwent whole-body DXA scans in Tromsø 5, Tromsø 6 and Tromsø 7, 
respectively. All participants attending one or more survey(s) were included in the analyses. Further, only participants 
aged 40 years and above were included in the analysis, due to few participants with DXA scans below 40 years in 
Tromsø 5 (n=51) and Tromsø 6 (n=5). After exclusions, the final sample for analysis consisted of 1662 (62% women, 
40-84 years) participants from Tromsø 5, 901 (63% women, 40-88 years) participants from Tromsø 6 and 3670 (59% 
women, 40-87 years) participants from Tromsø 7 (Figure 1).  
 
This project was approved by the Regional Committee for Medical Research Ethics (REC North reference 
2017/1967). All participants gave written informed consent. 
 
Body composition measures 
In all three surveys, total body DXA scans were performed with Lunar Prodigy Advance (GE Medical Systems, 
Madison, WI, USA) in accordance with protocols from the manufacturer. The DXA machine was calibrated each 
morning with a phantom. Post-scanned images were inspected by technicians and corrected if necessary. To ensure 
comparison between surveys, fat mass and lean mass were derived with Basic Mode Analysis, and VAT mass was 
derived with Enhanced Mode Analysis. Total body fat, lean and VAT mass were included directly from DXA from all 
three surveys. Total body fat and lean mass percentage was included directly from the DXA scans in Tromsø 6 and 
Tromsø 7, and calculated as total body fat or lean mass, respectively, divided by total body mass*100 in Tromsø 5. 
Percent VAT was calculated as VAT mass divided by total body fat mass in the android area *100. Total body fat 
mass in the android area was not available from Tromsø 5. Thus, VAT in percent was only available from Tromsø 6 
and Tromsø 7, and therefore, analysis of trend in VAT was performed for VAT in grams only. It should also be noted 
that of the 1662 participants with total body DXA scans in Tromsø 5, VAT mass measures were available for 284 of 
them, all participants attending total body scans had valid VAT mass measures from Tromsø 6. In Tromsø 7, 3675 
participants had valid VAT mass measures. Two participants with VAT percent values >100 in Tromsø 7 were 
excluded from analysis of VAT, thus 3673 participants with valid VAT measures were included in Tromsø 7. 
Participants with VAT mass equal to 0 had their values transformed into the lowest registered value of VAT mass in 
the sample, which was 2 gram in both Tromsø 6 (n=5) and Tromsø 7 (n=10). There were no 0-values of VAT in 
Tromsø 5.  
 
Statistical analyses 
We used STATA 16 (STATA Corp LP Texas, USA) to analyze both secular and longitudinal trends in body 
composition across surveys. Total body mass consists of fat mass and lean mass, thus we have presented results from 
lean mass analysis in supplementary tables. Mean values are presented with standard deviation (SD) or 95 % 
confidence intervals (CIs). To examine whether there were systematic differences in study population characteristics 
between those who re-participated in two or three of the surveys compared to those who participated in only one of the 
surveys, we present sex-adjusted mean values and proportions of cardiometabolic risk factors in 10-year age-groups 
(Table S1) (all participants in Tromsø 6 attended Tromsø 5 and/or Tromsø 7).  
 
Secular trends 
We used descriptive analysis to present mean total body fat, lean (kg and %), VAT mass (g and %), BMI (kg/m2), 
body weight (kg) and waist circumference (cm) in strata of 10 year-age groups for all three surveys (Table 1, Table 
S2). We used kernel density plots to present distributions of total body fat, lean and VAT mass at all three different 
surveys (Figure 2, Figure S1). To visualize secular trends in total body fat and lean mass we plotted mean values from 
birth year-adjusted generalized estimation equation (GEE) analysis of each body composition measure at each survey 
(Figure 3, Figure S2).  
 
Longitudinal trends 
Because we did not have complete repeated measures for all included participants, and to account for repeated 
measures in the 940 participants attending two or more of the three surveys (of which 382 attended all three) we used 
GEE analysis (which estimates values for all participants attending one of the surveys) to examine the longitudinal 
trends overall and in 10 year-age groups (attained age in Tromsø 5, 2001). Longitudinal change in total body fat, lean 
and VAT mass across surveys were presented by adjusting for birth year using GEE analysis (Table 2, Table S3). 
Further, we assessed whether longitudinal change in body composition differed between different age-groups by 
performing GEE analysis in strata of attained age-groups in 2001 (40-49, 50-59, 60-69 and 70-79 years). Only 
participants aged < 80 years were included in these analyses because few participants were 80 years and older (n=74). 
In separate models we included two-way interaction terms between indicator variables of attained 10-year age-groups 
in 2001 and an ordinal variable of time (Table 3 and Table S4). All analyses are presented for women and men 
separately. P-values < 0.05 were considered statistically significant.  
 
Results 
There was a higher proportion of women (58-63%) than men in all three surveys, and a higher mean age in Tromsø 6 
(68.5 and 69.9 years in women and men, respectively) compared to Tromsø 5 (65.2 and 66.5 years in women and men, 
respectively) and Tromsø 7 (66.7 and 66.2 years in women and men, respectively). There were minor differences in 
cardiometabolic risk factors between those attending one compared to two or more DXA scans (Table S1).  
 
Secular trends 
Overall, mean total body fat and VAT mass increased across the three surveys (Table 1). Correspondingly, total body 
lean mass % was slightly lower in Tromsø 7 than Tromsø 5 and 6 (Table S2). Overall, BMI (kg/m2) and waist 
circumference (cm) in women increased between 2001 to 2007-2008 but remained relatively stable between 2007-
2008 to 2015-2016. In men, BMI and waist circumference increased across the three surveys. Overall body weight 
(kg) increased between the three surveys in both women and men (Table 1). The kernel density plots indicate that, for 
each survey added, the distributions for fat and VAT shifted to the right in both women and men. Density plots for 
lean mass in kg were slightly shifted to the right in men only, while lean mass in percent were shifted to the left for 
each added survey (Figure 2 and Figure S1).  
Figure 3 shows that both total body fat and VAT mass increased from Tromsø 5 to Tromsø 6, and a much steeper 
increase was observed from Tromsø 6 to Tromsø 7. Total body fat mass was higher in women compared to men, while 
VAT mass was higher in men compared to women across all surveys (p<0.001 for both). VAT mass increased more 
rapidly in men than women over time (p<0.001). Overall, absolute body lean mass was higher in men than women, 
and lean mass (kg) remained stable across surveys in both women and men (Figure S2). Percent lean mass, on the 
other hand, decreased across surveys, especially from Tromsø 6 to Tromsø 7, which aligns with the increased absolute 
values of fat mass and the stable trend in lean mass (Figure S2).   
 
Longitudinal trends 
Results from GEE analyses (Table 2) show that total body fat mass increased across all surveys. There was a small 
increase from Tromsø 5 to Tromsø 6 (0.2 kg and 0.1 body fat % increase in women, and 0.5 kg and 0.6 body fat % 
points increase in men), while the increase from Tromsø 5 to Tromsø 7 was more pronounced (1.8 kg and 2.3 body fat 
% increase in women, and 3.0 kg and 3.7 body fat % increase in men). Also VAT mass increased across the follow-up 
period from Tromsø 5 to Tromsø 7 (200 g and 365 g in women and men, respectively), while a smaller increase was 
observed between Tromsø 5 and Tromsø 6 (48 g and 103 g increase in women and men, respectively). From Tromsø 6 
to Tromsø 7 VAT percent increased by 5% in both women and men.  
Table 3 shows that mean total body fat and VAT mass were lowest in the youngest age group (40-49 years) in Tromsø 
5. The largest estimated increase in fat and VAT mass between Tromsø 5 and Tromsø 7 was observed in the same 
age-group (40-49 years) with an increase of 3.9 kg (4.0%) fat mass and 293 g VAT mass in women and 4.5 kg (4.1%) 
fat mass and 806 g VAT mass in men. The difference in estimated increase between age groups was not significant in 
men for fat nor for VAT mass (Table 3). In sensitivity-analyses including only participants with repeated DXA scans 




In these secular and longitudinal analyses using a population-based sample we found that both total body fat and VAT 
mass increased over the two last decades in both women and men. The increases in total body fat and VAT mass were 
more pronounced in the last decade, and in the youngest age-groups (but statistically significantly different in women 
only).   
 
Secular trends 
We observed an increase in mean body fat and VAT mass across time. Previous literature on the secular trend in 
DXA-derived fat and VAT mass in adults is scarce, thus we were unable to compare our results with other studies. 
Overall, body weight increased across time, and in men, there was an increasing trend in both BMI and waist 
circumference across time. In women, neither BMI nor waist circumference increased between 2007-2008 to 2015-
2016. The differences in mean BMI and waist circumference were, however, clinically minor between the two latter 
surveys. In addition, we have previously shown that DXA-derived VAT strongly correlates to the more commonly 
available anthropometric measures and then concluded that these measures are satisfactory substitutes for the DXA-
derived measures (15).   
 
Longitudinal trends 
The longitudinal trends showed that fat and VAT mass increased in both women and men, in all age-groups, except 
for body fat in women aged 70-79. Further, the trends in fat (kg and %), VAT mass and lean mass were more 
prominent in men than women. This corresponds with findings from a previous study of 2040 elderly (aged 70-79 
years) with a follow-up of two years (11). Previous longitudinal studies have shown that body fat increases and lean 
mass decreases with increasing age (7, 8, 10-12). The trends in body composition were present also after adjusting for 
age, which implies that change in body composition may not only be an effect of age, but also an effect of time. The 
changes in body composition differed between age groups and the younger part of the population had a more 
unfavorable change in body composition over time, although age group differences in men were non-significant. 
These generational differences are also observed in studies with longer follow-up of participants in the Tromsø Study 
(16-19) and other studies (20-23) where the younger birth cohorts experienced larger increases in weight, BMI and 
waist circumference than the older birth cohorts. The more pronounced increase in overweight in younger populations 
is a cause of concern for this generation’s future health.  
 
Body composition trends and the paradox with cardiometabolic risk 
Contrasting the documented increase in overweight, other cardiometabolic risk factors, such as total cholesterol (24, 
25), blood pressure (26, 27), and overall burden of cardiometabolic risk (28-31) have decreased, both in this study 
population as well as in other high-income countries. In this study population, leisure-time physical activity levels (32) 
and grip strength (improved physical function) (33) has increased over time. Thus, the population seems to be in 
overall better health, while the trend in body composition suggests a health hazard. It is a paradox that the population 
is becoming physically stronger, while simultaneously muscular mass decreases, and further, that the cardiometabolic 
risk profile health improves while simultaneously the most metabolically harmful fat, VAT mass, increases. We may 
speculate that recent improvements in cardiometabolic health can be obstructed by the increase in prevalence of 
obesity in the younger generations.  
 
Strengths and limitations 
To our knowledge, no other study has presented secular trends in DXA-derived body composition in a general adult 
population and although previous longitudinal studies have found similar results, these studies examined changes in 
body composition by DXA in mostly elderly participants (65 years and older) and with shorter follow-up (a maximum 
of 5 years) (8, 10-12). We have included participants aged 40-88 years with 14 years of follow-up (1662, 901 and 
3670 participants in Tromsø 5, Tromsø 6 and Tromsø 7, respectively). Notably, we do not have repeated measures for 
all participants. A total of 940 participants attended two or more of the DXA scans (two or more repeated measures) 
and only 382 participants attended all three DXA scans (three repeated measures). We performed separate analyses for 
both those who attended two or more times, and for those who attended all three DXA scans, and found similar 
results. Further, we examined cardiometabolic risk factors in those attending only one survey and in those attending 
two or more surveys and found that the clinical differences were minor. Of the 1662 participants in Tromsø 5, only 
284 participants had valid VAT measures. The CoreScan EnCore software application for VAT extraction was not 
available in Tromsø 5 (2001). The images were therefore reanalyzed in 2019, and at this point many total body images 
were unavailable for extraction of VAT-measures. 
As for all population-based studies, selection bias may influence the results. Attenders in population studies tend to 
have a more favorable health profile than the non-attenders (34, 35). This implicate that mean values of fat mass and 
VAT mass in the three surveys may be lower in the present study than in the general population. 
Another limitation is the potential measurement error of the DXA equipment. Although Lunar Prodigy DXA was used 
in all three surveys, the more advanced Lunar iDXA machine could potentially have provided higher precision. 
Because all measurements were performed using identical protocols and equipment, we do not believe that our results 
are distorted by measurement error. Further, the inconsistency in VAT measures increase with increasing obesity (36). 
However, the least significant change for VAT mass is reported to be ± 130 g, meaning than observed changes larger 
than 130 g, as mostly observed in our study, can be considered actual changes (36). The results from this study is 
generalizable to similar populations measured with the same equipment as used in the current study. 
 
Conclusion 
During 2001 to 2016, fat mass and VAT mass increased while lean mass remained stable, in both sexes and all age-
groups in this Norwegian general population. The findings confirm the observed unhealthy increase in general and 
abdominal obesity measured by traditional anthropometric measures. Particularly worrying is the more pronounced 
increase in the last decade, and in the younger age-groups.  
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Figure 1: Inclusion of participants from Tromsø 5 (2001), Tromsø 6 (2007-2008) and Tromsø 7 (2015-2016). The 
Tromsø Study 2001-2016. 
Figure 2: Kernel density plots of the distribution of body fat (kilograms and %) in women and men >40 years in 
Tromsø 5, 2001 (blue line), Tromsø 6, 2007-2008 (red line) and Tromsø 7, 2015-2016 (green line). The Tromsø Study 
2001-2016. 
Cont. Figure 2: Kernel density plots of the distribution visceral adipose tissue (grams and %) in women and men >40 
years in Tromsø 5, 2001 (blue line), Tromsø 6, 2007-2008 (red line) and Tromsø 7, 2015-2016 (green line). The 
Tromsø Study 2001-2016. 
Figure 3: Trends in age adjusted mean body fat (kilograms and %) and visceral adipose tissue (grams and %) mass in 
women (red line) and men (blue line). The Tromsø Study 2001–2016.  
kg; kilograms, %; percent 
Each dot represents mean fat mass or mean visceral adipose tissue in Tromsø 5 (2001), Tromsø 6 (2007-2008) 
and Tromsø 7 (2015-2016). 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































           
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































                   


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































             
          

























































































































































































































































































































































































































































   








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































       















































































































































































































































































































































































1. List of links to invitations, information brochures, consent forms and questionnaires in 
Tromsø 5 (2001), Tromsø 6 (2007-2008) and Tromsø 7 (2015-2016) 
2. Invitation to extended examination Tromsø 5 (2001) 
3. Invitation to extended examination Tromsø 6 (2007-2008) 
4. Invitation to extended examination Tromsø 7 (2015-2016) 
5. Approval for the study from the Regional Committees for Medical and Health Research 







































List of links to invitations, information brochures, consent forms and questionnaires in 













































Links to invitations, information brochures, consent forms and questionnaires 
Tromsø 5-7 
 
Tromsø 5 (2001) – basic examination 
- Invitation: https://uit.no/Content/82032/innkalling_tr5.pdf  
- Consent form: https://uit.no/Content/710358/cache=20203011130454/samtykkerklaering.tromso5.pdf  
Tromsø 5 (2001) – extended examination 
- Invitation: see appendix 2 
 
Tromsø 6 (2007-2008) – basic examination 
- Invitation: https://uit.no/Content/100340/Forespoersel_om_deltakelse_t6.pdf   
- Consent form: https://uit.no/Content/111929/Samtykke%20Tr6.pdf  
Tromsø 6 (2007-2008) – extended examination 
- Invitation: see appendix 3 
 
Tromsø 7 (2015-2016) – basic examination 
- Invitation: https://uit.no/Content/710341/cache=20203011123325/brosjyre.troms%C3%B87.pdf  
- Questionnaire: https://uit.no/Content/710342/cache=20203011123337/Q1%2BTroms%C3%B8%2B7.pdf   
- Consent form: 
https://uit.no/Content/575211/cache=20180805144729/Samtykke.den7.Tromsoundersokelsen.pdf  
Tromsø 7 (2015-2016) – extended examination 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Vil du delta i Spesialundersøkelsen? 
 
Rundt halvparten av de som deltar i Hovedundersøkelsen blir spurt om å delta i en oppfølgende 
Spesialundersøkelse. Denne undersøkelsen tar cirka to timer, avhengig av hvor mange deler du er 
invitert til. Det er frivillig å delta.  
Vi minner samtidig om utfylling av kostholds skjemaet du fikk utlevert ved første oppmøte, dersom 
du ikke har gjort det allerede.  
 
Tid og sted 







Vi håper den avtalte timen passer. Dersom du må bytte time, ber vi om at du gir beskjed tidligst 
mulig på telefon: 77 62 07 00 (telefontreffetid kl. 09.00 -15.00) eller per e-post: tromso7@uit.no. 
 
Undersøkelser som utføres ved Spesialundersøkelsen. 
Blodprøve 
Det tas blodprøver av alle ved oppmøte.  
 
Urinprøve 
Vi ber om at du tar tre morgen-urinprøver. Du har fått ett uringlass for hver morgen, merket 1, 2, og 
3. Første prøve tas to dager før undersøkelsesdagen, den siste tas samme morgen som 
undersøkelsen. Følg bruksanvisningen og lever prøvene når du møter til Spesialundersøkelsen. 
 
Avføringsprøve 
Vi minner om å sende inn avføringsprøven du fikk utstyr til ved første oppmøte, innen 24 timer etter 
at du tok prøven. Bruk konvolutten du fikk utdelt eller avlever prøven ved Spesialundersøkelsen 
(innen 24 timer).  
 
 
Du inviteres videre til én eller flere av følgende undersøkelser: 
 
EKG  
Registrering av hjerterytmen utføres via elektroder som festes på brystet.  
 
Kognitiv funksjon  
Kognitiv funksjon undersøkes ved hjelp av enkle spørsmål knyttet til gjenkjenning av ord, kobling 





Fysisk funksjon  
Fysisk funksjon undersøkes ved test av balanse, gange og gripestyrke. 
 
Ultralyd av halspulsåre  
Halspulsåren undersøkes for å se etter forkalkninger og innsnevringer av årene. Undersøkelsen 
kartlegger også blodforsyningen til hjernen. 
 
Fotografering av øyebunnen  
Det gis en øyedråpe i hvert øye en tid før fotografering for at pupillene skal utvide seg. Synet kan 
forbigående bli noe uklart. Effekten avtar etter ca en time og går deretter gradvis over. Det anbefales 
å ta med solbriller da sterkt lys kan oppleves ubehagelig når pupillen er utvidet.  
Det gjøres også en enkel synstest.  
 
Lungefunksjonen  
Lungefunksjonen testes ved at du puster så hardt du klarer gjennom et munnstykke. I tillegg vil det 
gjøres lydopptak av lungelyder og hjertelyder. 
 
Måling av beintetthet.  
Måling av beintetthet og kroppssammensetning gjøres ved hjelp av et eget apparat (DEXA). 
 
Ultralyd av hjertet  
Ultralyd av hjertet utføres for å undersøke hjertets form og funksjon. 
 
Måling av fysisk aktivitet  
Graden av fysisk aktivitet måles ved å ha en aktivitetsmåler festet til hoften i en uke. Noen deltakere 
får i tillegg en aktivitetsmåler festet til brystet, i ett døgn. 
 
Påkledning 
Av hensyn til undersøkelsene ber vi om at du har på lett påkledning. Ha gjerne på kortermet plagg 
og løse bukser, og unngå strømpebukser og høye hæler. Ved undersøkelse av hjertet må man ta av 
seg på overkroppen og ha tilgang til bar hud på ankelen. Ved undersøkelse av beintetthet kan det 
ikke være metallgjenstander i klærne og på kroppen, som glidelås, knapper eller hemper av metall, 
smykker, ringer mm. Fotografering av øyebunnen gjennomføres uten linser, det anbefales derfor å ha 
på briller. Ta gjerne med solbriller som beskytter mot skarpt lys etter øyeundersøkelsen. 
 
Viktig hvis du kjører bil til undersøkelsen  
Etter drypping med øyedråper (Tropikamid) anbefales det å vente til man føler at synet har 
normalisert seg nok til at man kan kjøre bil på en trygg måte. Effekten av dråpene avtar etter ca 1 




Dersom resultatet av prøvene viser at det er nødvendig med oppfølging av lege, blir du orientert om 
det. Noen deltakere vil i ettertid bli spurt om å delta i videre undersøkelser. Du vil da få en 
forespørsel i posten. Det er frivillig å delta i videre undersøkelser. 
 
 
Vel møtt til undersøkelsen! 
Appendix 4 
 













































Vil du delta i Spesialundersøkelsen?
Spesialundersøkelsen er en utvidelse av Tromsøundersøkelsen. 
Om lag halvparten av de som deltar i første del av undersøkelsen blir spurt om å delta. Det 
er frivillig å delta i Spesialundersøkelsen. 
Tid og sted 
Du har fått time
Undersøkelsen foregår i 2. etasje, samme sted som første del av Tromsøundersøkelsen.  
Varigheten av spesialundersøkelsen tar en til to timer. 
Vi håper du kan benytte den avtalte time. Dersom du må bytte time, ber vi om 
at du gir beskjed på telefon: 77 64 48 16 mellom kl.09.00-11.00,  eller 
e-post: tromsous@ism.uit.no
Undersøkelser som utføres
Ultralyd av blodårer og hjerte
Alle som møter vil få undersøkt halspulsårer. Om lag halvparten vil også få undersøkt 
hjertets form og funksjon.
Måling av beintetthet og kroppens fettmengde
Alle vil få undersøkt beintetthet, men type undersøkelse vil variere.
Fotografering av øyebunn
Vi vil ta fotografi  av øyebunnen av alle deltakere. Du vil få en øyedråpe i hvert øye en tid 
før fotografering. Dette kan svi noe og synet kan forbigående bli noe uklart. Effekten er 
borte etter en time. Alle får tilbud om en enkel synstest som du vil få svar på med en gang.
Tester av hukommelse
Tester av hukommelse gjøres ved hjelp av enkle spørsmål og omfatter også evne til gjen-












Ved EKG-registrering festes ledninger til kroppen. Blodtrykket måles både på overarmen 
og ved ankelen.
Pusteprøve
Du skal puste så hardt du klarer inn i et apparat. Hvor mye luft som blåses ut per sekund, 
er et mål på hvordan lungene fungerer.
Bakterieprøve fra nese og hals
Bakterieprøven gjøres på samme måte som sist hos de som fi kk utført denne prøven ved 
første frammøte. 
Blodprøve
Det vil tas ny blodprøve av alle.
Intervju
Et utvalg vil bli spurt om bruk av antibiotika (penicillin og lignende legemidler) de siste 24 
timer.
Urinprøve
Du har fått utlevert tre uringlass merket 1, 2, og 3. Vi ønsker at du de siste tre dagene før 
spesialundersøkelsen tar en morgenurinprøve. Du har fått ett glass for hver morgen. Følg 
bruksanvisningen. 
Påkledning
Av hensyn til måling av blodtrykk, taking av EKG og ultralydundersøkelsen ber vi om at 
du tar på plagg som ikke strammer på armer og bein. Ved undersøkelse av hjertet er det 
nødvendig å ta av seg på overkroppen. Ved undersøkelse av beintetthet trenger du ikke kle 
av deg, men det er viktig ikke å ha metallgjenstander i klærne og på kroppen, for eksempel 
glidelås, knapper eller hemper av metall, smykker, ringer mm.
Videre oppfølging
Dersom resultatet av prøvene viser at det er nødvendig med oppfølging av lege, vil du bli 
orientert om det. 
Noen deltakere vil i ettertid bli spurt om å delta i videre undersøkelser. Hvis dette gjelder 
deg, vil du få en forespørsel i posten. Det er frivillig å delta i videre undersøkelser.
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andre tradisjonelle overvektsmål? 3) Hvilke kostholdsmønster samsvarer best med god kardiometabolsk
helse?
Vurdering
Formålet med prosjektet er å kartlegge kosthold og næringsinntak i befolkningen, studere sammenhengen
mellom kosthold og kardiometabolsk risikoprofil i befolkningen og studere trender i kroppssammensetning
og andre overvektsmål i en definert befolkning og tidsperiode.
Vurdering av om det avgitte samtykket er dekkende
Prosjektet vil kun benytte seg av allerede innsamlet materiale som ligger innenfor hovedformålet med
Tromsøundersøkelsen. Skriftlig samtykke er innhentet, og deltakerne kan til enhver tid reservere seg mot at
deres data blir brukt i analyser. Data fra deltakere som har reservert seg vil ikke bli brukt i analysene.
Etter fullmakt er det fattet slikt
vedtak
Med hjemmel i helseforskningsloven §§ 2 og 10 godkjennes prosjektet.
Sluttmelding og søknad om prosjektendring
Prosjektleder skal sende sluttmelding til REK nord på eget skjema senest 31.07.2021, jf. hfl. §
12. Prosjektleder skal sende søknad om prosjektendring til REK nord dersom det skal gjøres vesentlige
endringer i forhold til de opplysninger som er gitt i søknaden, jf. hfl. § 11.
Klageadgang
Du kan klage på komiteens vedtak, jf. forvaltningsloven § 28 flg. Klagen sendes til REK nord. Klagefristen
er tre uker fra du mottar dette brevet. Dersom vedtaket opprettholdes av REK nord, sendes klagen videre til





rådgiver          
Kopi til:nina.emaus@uit.no
 
 
 
